Glaucoma

H7_GLAUCOMA

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H40-H42
  • Cause of death: ICD-10 H40-H42

2 out of 7 registries used, show all original rules.

26317

4. Check minimum number of events

None

26317

5. Include endpoints

27429

6. Filter based on genotype QC (FinnGen only)

27429

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 233920 143708 88340
Only index persons 193946 120923 73023
Unadjusted period prevalence (%)
Whole population 3.48 4.12 2.47
Only index persons 3.82 4.45 2.79
Median age at first event (years)
Whole population 68.10 68.91 66.78
Only index persons 67.32 68.15 65.94

-FinnGen-

Key figures

All Female Male
Number of individuals 27429 15875 11554
Unadjusted period prevalence (%) 5.28 5.41 5.09
Median age at first event (years) 66.45 65.80 67.34

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
24106
Matched controls
214662
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
CHC05
NOMESCO Finland
Iridotomy
92.3
323.0
1919
201
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
4898.6
323.0
547
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.5
323.0
12386
64117
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
32.4
323.0
1981
592
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
4852.1
323.0
542
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
6.1
323.0
6143
11471
3651A
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA SIMPLEX (AVOKULMA)]
+∞
323.0
458
*
S01ED51
ATC
timolol, combinations; ophthalmic
59.7
323.0
10269
2631
S01EC04
ATC
brinzolamide; ophthalmic
76.3
323.0
4922
719
H40
ICD-10 Finland
Glaucoma
42.8
323.0
1055
229
Z96.1
ICD-10 Finland
Presence of intraocular lens
4.7
323.0
6650
15961
ZXA10
NOMESCO Finland
Bilateral
2.2
323.0
5565
25376
WX140
NOMESCO Finland
Parabulbar anesthesy
5.3
323.0
2115
3825
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.6
323.0
1441
2915
S01EE04
ATC
travoprost; ophthalmic
44.7
323.0
2392
527
XCK00
NOMESCO Finland
Perimetry
23.8
323.0
6995
3627
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.5
323.0
7097
18214
114
Kela drug reimbursment
Glaucoma
89.3
323.0
13285
2906
S01EE05
ATC
tafluprost; ophthalmic
47.7
323.0
3914
868
S01EB01
ATC
pilocarpine; ophthalmic
60.1
323.0
779
119
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.9
323.0
11338
50187
CS494
NOMESCO Finland
Other visual field testing
23.4
323.0
1933
795
S01EE01
ATC
latanoprost; ophthalmic
54.4
323.0
8307
2055
H25.1
ICD-10 Finland
Senile nuclear cataract
2.7
323.0
9374
40979
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
148.4
323.0
1690
109
H40.11
ICD-10 Finland
Low pressure glaucoma
396.8
323.0
2711
68
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.5
323.0
10969
54245
XCK10
NOMESCO Finland
Photography of fundus of eye
4.5
323.0
4733
11158
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
+∞
323.0
331
*
H40.0
ICD-10 Finland
Glaucoma suspect
488.6
323.0
13616
563
CS2P4
NOMESCO Finland
Optic nerve head imaging
133.6
323.0
586
40
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.5
323.0
3714
14785
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
2089.4
323.0
4388
24
S01EA03
ATC
apraclonidine; ophthalmic
18.8
323.0
771
377
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
48.2
323.0
2123
429
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
1585.5
323.0
667
*
XCH05
NOMESCO Finland
Eye pressure longterm registration
303.4
323.0
1115
34
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.1
323.0
5320
8246
3650A
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]
+∞
323.0
379
*
H40.9
ICD-10 Finland
Glaucoma, unspecified
177.8
323.0
2098
115
S01ED01
ATC
timolol; ophthalmic
34.8
323.0
4282
1323
CHD00
NOMESCO Finland
Laser trabeculoplasty
708.7
323.0
1636
22
S01EA02
ATC
dipivefrine; ophthalmic
270.3
323.0
415
14
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
814.8
323.0
3790
49
S01EX03
ATC
NA
60.4
323.0
2606
430
H26.4
ICD-10 Finland
After-cataract
2.8
323.0
3307
11574
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
525.8
323.0
7396
178
S01ED02
ATC
betaxolol; ophthalmic
57.9
323.0
1099
177
S01EC01
ATC
acetazolamide; systemic
27.0
323.0
2148
774
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
5.2
323.0
2959
5612
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
172.8
323.0
3476
209
H40.8
ICD-10 Finland
Other glaucoma
280.9
323.0
376
12
S01EE03
ATC
bimatoprost; ophthalmic
67.0
323.0
2717
406
CHD99
NOMESCO Finland
Other filtering operation
1566.6
323.0
334
*
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
92.4
323.0
1109
112
S01EC54
ATC
brinzolamide, combinations; ophthalmic
102.8
323.0
1414
130
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
+∞
323.0
848
*
S01EC03
ATC
dorzolamide; ophthalmic
73.3
323.0
1713
224
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
31.5
323.0
3140
1016
CHD35
NOMESCO Finland
Laser goniopuncture
4129.0
323.0
464
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
2584.1
323.0
1415
5
H20.1
ICD-10 Finland
Chronic iridocyclitis
13.1
323.0
644
449
XCH00
NOMESCO Finland
Eye pressure measurement
10.6
323.0
2849
2673
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
3849.2
323.0
853
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
3.1
323.0
3085
9801
F93
ICPC
Glaucoma
50.4
287.6
363
65
37597
ICD-8 Finland
Glaucoma, Suspicio glaucomatis
+∞
287.4
288
*
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
2524.5
286.0
289
*
H40.12
ICD-10 Finland
Pigmentary glaucoma
526.7
282.4
293
5
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.1
273.2
1655
4957
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
6.9
264.4
707
935
H40.1
ICD-10 Finland
Primary open-angle glaucoma
77.6
254.4
301
35
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
4.7
252.6
924
1792
H34.8
ICD-10 Finland
Other retinal vascular occlusions
4.8
252.1
907
1728
37510
ICD-8 Finland
Glaucoma, Chronicum simplex
+∞
251.4
252
*
SPAT1009
SPAT
Measurement of intraocular pressure
6.3
219.2
626
905
CFW99
NOMESCO Finland
Other operation on conjunctiva
125.9
212.1
238
17
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
960.2
209.2
214
*
CKC12
NOMESCO Finland
Photocoagulation of retina
3.0
197.5
1230
3733
3651B
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]
+∞
196.5
197
*
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
1673.0
192.2
195
*
F43
ICPC
Eye, Other diagnostic procedure
5.1
184.8
630
1129
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.5
177.0
896
2331
H04.10
ICD-10 Finland
Dry eye syndrome
2.1
174.6
2321
10533
ZXA05
NOMESCO Finland
Left side
1.6
172.9
6202
38623
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.8
169.8
385
393
CKD40
NOMESCO Finland
Endophotocoagulation of retina
5.4
166.1
539
913
H25.8
ICD-10 Finland
Other senile cataract
1.8
165.1
3021
15441
H25.0
ICD-10 Finland
Senile incipient cataract
2.3
164.4
1748
7175
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
4.7
149.4
551
1074
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.3
144.8
780
2127
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.4
140.8
731
1937
ZXA00
NOMESCO Finland
Right side
1.5
139.4
6387
41663
H26.2
ICD-10 Finland
Complicated cataract
5.1
137.2
467
835
3708
FHL
Trabeculectomy or equivalent
1239.0
134.5
137
*
CK2P4
NOMESCO Finland
Optic nerve head light layer imaging (OCT)
51.3
132.3
166
29
S01BC03
ATC
diclofenac; ophthalmic
3.3
132.1
725
2004
ZXC20
NOMESCO Finland
Use of chemical agents
3.5
130.7
662
1720
H3603, E103
ICD-10 Finland
NA
6.7
124.3
336
451
37520
ICD-8 Finland
Glaucoma, Secondary
+∞
123.6
124
*
XCW10
NOMESCO Finland
Assessment of vision
9.1
120.1
267
264
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.7
119.7
865
2873
H40.21
ICD-10 Finland
Intermittent glaucoma with closed ventricular angle
1090.8
119.6
122
*
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
277.3
117.7
125
*
TCG20
NOMESCO Finland
Laser suture lysis in cornea or sclera
1072.9
117.6
120
*
S01BC05
ATC
ketorolac; ophthalmic
2.3
117.3
1139
4452
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.5
113.4
573
1486
CKD20
NOMESCO Finland
Removal of vitreous body substitute
9.1
113.0
251
248
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
3.5
111.3
555
1424
H52.1
ICD-10 Finland
Myopia
3.4
111.1
591
1595
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.5
108.9
539
1375
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
2.5
108.7
923
3366
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
6.4
104.3
292
412
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
9.6
104.2
224
209
CKD15
NOMESCO Finland
Injection of vitreous substitute
9.3
103.9
227
218
CHC03
NOMESCO Finland
Laser iridoplasty
242.3
101.0
108
*
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
2.4
101.0
898
3355
H16.0
ICD-10 Finland
Corneal ulcer
2.4
100.7
955
3685
F38
ICPC
Eye, Other laboratory test NEC
9.8
100.1
213
195
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
3.0
98.2
621
1894
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.0
96.8
1386
6415
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.6
95.3
770
2728
WX002
NOMESCO Finland
Sedation and analgesia
1.5
92.1
4303
27768
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
91.8
9043
66485
CKC15
NOMESCO Finland
Panretinal photocoagulation
5.2
91.3
302
524
A10AA01
ATC
NA
3.0
91.0
579
1774
SPAT1301
SPAT
No procedures
1.4
90.9
6846
48200
H40.29
ICD-10 Finland
Other [primary] glaucoma with closed ventricular angle
+∞
90.7
91
*
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
+∞
88.7
89
*
S01FA01
ATC
atropine; ophthalmic
6.9
88.6
233
302
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
6.9
88.0
233
305
A10AA02
ATC
NA
2.4
87.5
780
2914
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
3.3
86.6
473
1303
CA1ME
NOMESCO Finland
Ultrasound oculometry
5.4
85.9
272
449
CKC20
NOMESCO Finland
Cryopexy of undetached retina
10.5
85.1
174
148
H44.5
ICD-10 Finland
Degenerated conditions of globe
47.8
84.5
107
20
SPAT1325
SPAT
Vaccination
1.3
82.9
7664
55547
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.4
82.5
780
3004
T89
ICPC
Diabetes insulin dependent
2.4
80.2
712
2652
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
80.0
13635
107527
SPAT1263
SPAT
Sampling
1.3
79.7
8741
64860
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.7
79.6
1642
8610
H21.0
ICD-10 Finland
Hyphaema
9.9
78.8
166
150
H27.1
ICD-10 Finland
Dislocation of lens
8.0
78.2
187
210
CHD10
NOMESCO Finland
Trabeculectomy
713.5
77.8
80
*
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
3.8
77.7
349
822
SPAT1312
SPAT
General health counselling
1.3
77.6
6294
44590
CKC10
NOMESCO Finland
Local photocoagulation of retina
2.9
77.5
498
1537
WX142
NOMESCO Finland
Sub-tenon anesthesy
7.1
77.2
199
251
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
3.8
76.7
347
822
H3603, E113
ICD-10 Finland
NA
4.3
76.6
299
619
A98
ICPC
Health maint/preventive medicine
1.4
76.1
21177
178876
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
7.9
74.9
180
204
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.0
74.3
1035
4729
CD2S4
NOMESCO Finland
Photography of eye
7.0
73.5
191
244
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
72.5
7959
58823
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.7
71.8
1521
8031
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
3.3
71.5
384
1045
S01EX
ATC
Other antiglaucoma preparations
+∞
70.7
71
*
CFB00
NOMESCO Finland
Suture of conjunctiva
21.4
70.6
108
45
XCD20
NOMESCO Finland
Photoangiography of eye
2.8
70.1
471
1495
C08CA01
ATC
amlodipine; oral
1.3
68.9
8060
59981
H57.1
ICD-10 Finland
Ocular pain
2.4
68.8
611
2278
3652B
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[KROONINEN AHDASKULMAGLAUKOOMA]
+∞
68.7
69
*
H26.02
ICD-10 Finland
Presenil cataract
2.4
68.6
596
2198
SPAT1262
SPAT
Handing over of treatment supplies
1.4
68.3
3876
25770
SPAT1310
SPAT
Counselling related to known health issue
1.3
67.8
6415
46316
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
16.7
67.2
112
60
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
6.1
66.6
192
283
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
65.5
4322
29474
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.4
64.6
607
2328
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
5.4
64.5
203
334
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
58.0
63.8
78
12
R42
ICD-10 Finland
Dizziness and giddiness
1.4
63.5
4599
31817
SPAT1153
SPAT
Removal of sutures
1.3
63.0
6775
49685
H27.0
ICD-10 Finland
Aphakia
8.7
62.4
141
145
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
4.2
61.5
245
519
N02BE01
ATC
paracetamol; systemic, rectal
1.3
61.4
19047
159197
CKD60
NOMESCO Finland
Anterior vitrectomy
3.9
61.1
265
607
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
+∞
60.8
61
*
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.0
60.7
369
1099
H3601, E103
ICD-10 Finland
NA
4.5
60.7
229
460
S01FA04
ATC
cyclopentolate; ophthalmic
3.5
60.5
302
778
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
60.1
6179
44974
A10AE05
ATC
insulin detemir; parenteral
1.8
59.2
1091
5507
S18
ICPC
Laceration/cut
1.3
58.8
8763
66858
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
13.3
58.7
107
72
TCG10
NOMESCO Finland
Removal of sutures from cornea
5.6
58.6
180
288
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.6
58.6
216
424
H36.01
ICD-10 Finland
Diabetic maculopathy
3.3
58.4
309
833
H04AA01
ATC
glucagon; nasal, parenteral
2.8
56.3
374
1182
37512
ICD-8 Finland
Glaucoma, Chronicum capsulare
+∞
55.8
56
*
H18.1
ICD-10 Finland
Bullous keratopathy
10.1
55.4
115
102
H3600, E103
ICD-10 Finland
NA
4.1
54.6
227
501
A10AE04
ATC
insulin glargine; parenteral
1.5
54.4
1850
11044
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
53.3
9064
69974
H53.4
ICD-10 Finland
Visual field defects
2.4
52.9
470
1754
F29
ICPC
Eye symptom/complaint other
1.6
52.9
1497
8549
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.3
52.7
4948
35442
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
52.4
7181
54015
H54.4
ICD-10 Finland
Blindness, monocular
8.2
51.9
121
132
S01EX05
ATC
netarsudil; ophthalmic
+∞
51.8
52
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
51.0
5951
43841
AA1AD
NOMESCO Finland
CT of head and brain
1.3
50.9
5005
36054
F99
ICPC
Eye/adnexa disease other
4.7
50.5
182
350
CHC00
NOMESCO Finland
Iridotomy
124.9
50.3
56
*
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
8.4
49.5
114
122
SPAT1260
SPAT
Consultation of another employee
1.3
49.4
3515
24128
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
2.9
49.0
316
981
3652A
ICD-9 Finland
Glaucoma, Primary angle-closure glaucoma[AKUUTTI AHDASKULMAGLAUKOOMA]
+∞
48.8
49
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
48.5
3175
21501
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.3
48.3
189
395
CG2T4
NOMESCO Finland
Topography assessment of cornea
3.9
47.0
205
474
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
3.3
46.5
248
675
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
46.3
5906
43887
3711
FHL
Cyclodiateria or cryocoagulation
417.6
45.2
47
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
45.1
3662
25617
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.1
45.0
553
2403
H35.36
ICD-10 Finland
Macular cyst
4.0
44.6
186
413
CJF30
NOMESCO Finland
Reduction of dislocation of artificial lens
7.3
43.2
108
132
C09CA01
ATC
losartan; oral
1.3
42.8
4975
36488
E0000UV
ATC
NA
1.2
42.8
7384
56689
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.7
41.7
292
956
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
2.5
41.7
332
1171
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
41.4
1113
6263
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.0
41.4
559
2524
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
41.0
5603
41866
J01DB01
ATC
cefalexin; oral
1.2
40.4
17054
142683
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
4.0
40.0
167
372
H20.8
ICD-10 Finland
Other iridocyclitis
5.7
39.9
120
189
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
8.7
39.9
89
91
SPAT1053
SPAT
Memory test
1.3
39.9
3360
23584
H3601, E113
ICD-10 Finland
NA
2.4
39.8
340
1246
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.5
39.8
1699
10626
H52.2
ICD-10 Finland
Astigmatism
2.9
39.8
258
806
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
2.3
39.7
382
1487
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.6
39.4
292
989
-44
ICPC
Preventive immunization/medic
1.5
39.3
1666
10402
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.3
38.8
392
1561
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
38.8
2771
18968
S01AD03
ATC
aciclovir; ophthalmic
1.8
38.7
691
3448
CJF45
NOMESCO Finland
Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy
9.1
38.7
84
82
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.2
38.5
9169
72490
G03CA04
ATC
estriol; systemic, vaginal
1.5
38.0
1514
9336
H02.4
ICD-10 Finland
Ptosis of eyelid
1.9
37.7
554
2584
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
3.9
37.2
158
358
WX110
NOMESCO Finland
Local anesthesy
1.2
37.0
13101
107264
H13
ICPC
Plugged feeling ear
1.3
36.8
3555
25396
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
3.2
36.4
200
559
H01.0
ICD-10 Finland
Blepharitis
1.7
36.3
856
4650
37511
ICD-8 Finland
Glaucoma, Chronicum irritativum sive congestivum
+∞
35.9
36
*
C10AA01
ATC
simvastatin; oral
1.2
35.8
9916
79317
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
4.6
35.8
130
254
A10AE06
ATC
insulin degludec; parenteral
2.0
35.5
461
2049
H27.8
ICD-10 Finland
Other specified disorders of lens
5.4
35.4
110
181
C08CA13
ATC
lercanidipine; oral
1.3
35.1
2667
18408
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
34.7
903
5037
H33.4
ICD-10 Finland
Traction detachment of retina
7.2
34.4
86
106
3719
FHL
Other measure in this category
318.9
34.3
36
*
SPAT1097
SPAT
Recording of ECG
1.3
34.3
3004
21159
T90
ICPC
Diabetes non-insulin dependent
1.2
34.2
4613
34297
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
21.7
33.9
51
21
H52.0
ICD-10 Finland
Hypermetropia
2.4
33.8
294
1091
L17
ICPC
Foot/toe symptom/complaint
1.2
33.4
4750
35512
TCA15
NOMESCO Finland
Retrobulbar therapeutic injection into orbit
38.3
33.0
43
10
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
32.9
4250
31421
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
5.3
32.9
104
175
M79.6
ICD-10 Finland
Pain in limb
1.2
32.9
6678
51776
CFD10
NOMESCO Finland
Repair of conjunctiva
12.4
32.9
61
44
A28
ICPC
Limited function/disability NOS
1.3
32.6
3138
22372
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
32.5
3935
28869
Z94.7
ICD-10 Finland
Corneal transplant status
4.5
32.2
119
237
CKC60
NOMESCO Finland
Local buckling of sclera using implant
3.7
31.9
147
359
3656C
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA NEOVASCULARE]
+∞
31.9
32
*
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
3.7
31.7
144
348
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.3
31.6
2716
19068
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
12.6
31.6
58
41
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
3.2
31.1
173
489
36401
ICD-8 Finland
Iritis, Iridocyclitis glaucomatosa. Syndroma Posner-Schlossman, heterochromia iridis
+∞
30.9
31
*
37500
ICD-8 Finland
Glaucoma, Primary, acute
+∞
30.9
31
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
30.8
2450
17005
SPAT1043
SPAT
Audiometry
1.3
30.6
2091
14186
S01AX11
ATC
[U] ofloxacin; ophthalmic
1.7
30.5
679
3632
H31.4
ICD-10 Finland
Choroidal detachment
18.6
30.4
48
23
P20
ICPC
Memory disturbance
1.3
30.0
2543
17810
3661A
ICD-9 Finland
Cataract, Senile cataract
2.3
29.4
287
1126
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.2
29.4
5905
45636
L57.0
ICD-10 Finland
Actinic keratosis
1.3
29.3
2014
13675
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
3.2
29.2
158
438
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
29.2
2970
21300
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.8
29.2
501
2469
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
29.2
1724
11422
C10AA05
ATC
atorvastatin; oral
1.2
29.0
8134
64741
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
28.9
4818
36545
R53
ICD-10 Finland
Malaise and fatigue
1.2
28.6
3746
27688
H40.2
ICD-10 Finland
Primary angle-closure glaucoma
269.4
28.4
30
*
H02
ICPC
Hearing complaint
1.3
28.4
2399
16786
CKD50
NOMESCO Finland
Endodiathermy of retina
6.6
28.2
75
102
S01KA02
ATC
hypromellose; ophthalmic
2.0
28.2
372
1670
J01CA08
ATC
pivmecillinam; oral
1.2
28.1
7193
56766
3656F
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]
+∞
27.9
28
*
3659X
ICD-9 Finland
Glaucoma, Unspecified glaucoma
+∞
27.9
28
*
H30.2
ICD-10 Finland
Posterior cyclitis
5.6
27.4
82
130
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
27.4
965
5790
H16.9
ICD-10 Finland
Keratitis, unspecified
2.3
27.3
262
1022
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
1.9
27.0
388
1799
M02AA07
ATC
piroxicam; topical
1.2
27.0
7480
59382
N03AX12
ATC
gabapentin; oral
1.3
26.9
2741
19651
37598
ICD-8 Finland
Glaucoma, Aliud definitum
+∞
26.9
27
*
3656B
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUKOMASYKLIITTINEN KRIISI,SYNDR POSSNER-SCHOSSMAN]
+∞
26.9
27
*
SPAT1304
SPAT
Counselling and guidance related to ageing
1.4
26.6
1413
9194
R51.80
ICD-10 Finland
Headache
1.3
26.5
2173
15131
Q15.0
ICD-10 Finland
Congenital glaucoma
89.2
26.3
30
*
H54.1
ICD-10 Finland
Severe visual impairment, binocular
7.4
26.2
64
77
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.2
26.2
3162
23131
WX720
NOMESCO Finland
Own respiration
1.6
26.2
637
3492
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.5
26.1
1004
6143
CWD00
NOMESCO Finland
Reoperation for superficial heamorrhage in eye and adjacent structures
19.8
26.0
40
18
3650B
ICD-9 Finland
Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AHDASKULMA)]
+∞
25.9
26
*
A02BC02
ATC
pantoprazole; systemic
1.2
25.9
13516
112556
UJF32
NOMESCO Finland
Coloscopy
1.2
25.8
5139
39588
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
25.8
5290
40864
CKC70
NOMESCO Finland
Circular buckling of sclera
4.1
25.7
104
228
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
25.7
1439
9449
CDC00
NOMESCO Finland
Enucleation of eye
18.8
25.5
40
19
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
3.6
25.5
119
296
SPAT1254
SPAT
Administration of medicine
1.3
25.5
2728
19671
C10AA07
ATC
rosuvastatin; oral
1.2
25.3
4698
35947
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.6
25.3
194
675
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
5.9
25.2
72
108
S01FA02
ATC
scopolamine; ophthalmic
2.6
25.2
195
682
N06AX11
ATC
mirtazapine; oral
1.2
25.2
5738
44724
ZX198
NOMESCO Finland
Other local administration
2.4
25.2
219
814
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
2.8
25.0
170
552
M01AX05
ATC
glucosamine; oral
1.2
24.9
4292
32591
SPAT1229
SPAT
Assessment of need for aid
1.4
24.9
1559
10419
H33.3
ICD-10 Finland
Retinal breaks without detachment
1.6
24.8
594
3244
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
24.8
11225
92355
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
24.8
4729
36271
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.0
24.7
330
1490
H54.0
ICD-10 Finland
Blindness, binocular
8.2
24.5
56
61
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.3
24.3
2468
17668
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
3.5
24.2
116
295
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
24.2
2417
17271
C03CA01
ATC
furosemide; systemic
1.2
24.0
6460
51044
CH2X4
NOMESCO Finland
Optical coherence tomography (OCT) of iris and iridocorneal angle
8.3
23.9
54
58
CKC30
NOMESCO Finland
Cryopexy of detached retina
3.2
23.6
127
353
N17
ICPC
Vertigo/dizziness
1.3
23.5
1997
13964
CHW99
NOMESCO Finland
Other operation on anterior chamber, anterior chamber angle, iris or ciliary body
15.8
23.5
39
22
H91.1
ICD-10 Finland
Presbycusis
1.4
23.4
1193
7705
F01
ICPC
Eye pain
1.8
23.4
410
2041
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.6
23.2
688
3969
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
23.2
5663
44357
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
23.1
1206
7820
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
6.6
22.8
60
81
H26.3
ICD-10 Finland
Drug-induced cataract
3.1
22.8
130
375
H18.8
ICD-10 Finland
Other specified disorders of cornea
3.2
22.8
125
353
-1
NOMESCO Finland
NA
1.2
22.6
5233
40786
F27
ICPC
Fear of eye disease
2.5
22.6
177
624
S01EB02
ATC
carbachol; ophthalmic
213.8
22.5
24
*
3663A
ICD-9 Finland
Cataract secondary to ocular disorders
4.7
22.4
78
148
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
4.0
22.2
90
199
H3600, E113
ICD-10 Finland
NA
2.1
22.0
262
1131
S01BA09
ATC
clobetasone; ophthalmic
9.1
22.0
47
46
CHB30
NOMESCO Finland
Goniotomy
+∞
21.9
22
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
21.9
12722
106123
CJF15
NOMESCO Finland
Secondary implantation of skleral fixed artificial lens in posterior chamber
7.2
21.8
54
67
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
6.0
21.8
61
90
WX144
NOMESCO Finland
Subconjunctival anesthesy
2.2
21.7
226
918
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
21.7
7114
56976
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
1.7
21.7
492
2650
N03AX16
ATC
pregabalin; oral
1.2
21.7
4304
33073
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
21.6
5419
42489
3702
FHL
Trabeculotomy
204.9
21.6
23
*
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
3.6
21.4
99
246
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.3
21.2
1640
11315
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
21.2
3907
29812
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
7.5
21.2
51
61
H34.1
ICD-10 Finland
Central retinal artery occlusion
2.8
21.1
137
432
H44.4
ICD-10 Finland
Hypotony of eye
28.7
21.1
29
9
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
21.0
4545
35182
CJG15
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial lens in anterior chamber and iridectomy or iridotomy
10.8
21.0
41
34
3651C
ICD-9 Finland
Glaucoma, Open-angle glaucoma[MATALAPAINEGLAUKOOMA]
+∞
20.9
21
*
3651D
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA PIGMENTOSUM]
+∞
20.9
21
*
D07AC01
ATC
betamethasone; topical
1.2
20.9
6328
50345
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
2.5
20.9
166
590
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
20.9
868
10594
A02BC03
ATC
lansoprazole; oral
1.2
20.7
5758
45497
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.1
20.7
9211
75337
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
4.2
20.6
80
170
3703
FHL
Laser operation on ventricular angle under general anesthesia
196.0
20.6
22
*
CHD30
NOMESCO Finland
Laser trabeculectomy
196.0
20.6
22
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.2
20.5
2713
20012
ZXC50
NOMESCO Finland
Cryotherapy
1.6
20.5
558
3155
A02BC05
ATC
esomeprazole; systemic
1.1
20.4
7790
63014
205
Kela drug reimbursment
Chronic hypertension
1.2
20.0
6168
49108
3656E
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POSTTRAUMATICUM]
+∞
19.9
20
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
5.6
19.9
59
94
CBJ40
NOMESCO Finland
Resection of levator muscle of eyelid
2.7
19.9
138
454
K85
ICPC
Elevated blood pressure
1.2
19.8
2829
21032
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.3
19.8
1493
10261
F28
ICPC
Limited function/disability (F)
2.9
19.8
125
389
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.2
19.8
4905
38385
J05AB01
ATC
aciclovir; systemic
1.2
19.7
3562
27105
CG2S4
NOMESCO Finland
Photography of cornea
3.4
19.7
96
249
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.0
19.6
118
355
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
2.7
19.5
138
461
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.3
19.5
1930
13756
M48.0
ICD-10 Finland
Spinal stenosis
1.2
19.5
2354
17183
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
3.0
19.3
114
340
CKD99
NOMESCO Finland
Other intraoclular operations on vitreous body and retina
9.1
19.3
41
40
3643
FHL
Vitrectomy through pars Plana
5.2
19.3
61
105
CBG00
NOMESCO Finland
Epilation of cilia by electrolysis
3.9
19.3
82
190
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.5
19.3
594
3461
SPAT1101
SPAT
Orthostatic test
1.4
19.2
849
5338
H26.1
ICD-10 Finland
Traumatic cataract
3.7
19.2
85
204
R3120
NOMESCO Finland
Training in mobility skills
8.0
19.2
44
49
H33.5
ICD-10 Finland
Other retinal detachments
2.6
19.1
145
503
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
2.8
19.1
123
389
CWW99
NOMESCO Finland
Other reoperation on eye and adjacent structures
14.0
19.1
33
21
H3603, E107
ICD-10 Finland
NA
9.7
18.9
39
36
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
18.8
3874
29828
J01CA04
ATC
amoxicillin; systemic
1.1
18.7
16006
136189
R01AD09
ATC
mometasone; nasal
1.1
18.6
7575
61450
J01EA01
ATC
trimethoprim; systemic
1.2
18.6
4744
37182
H3603, E109
ICD-10 Finland
NA
12.1
18.5
34
25
CJE15
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in anterior chamber and iridectomy or iridotomy
2.4
18.4
164
622
H02AB06
ATC
prednisolone; systemic
1.1
18.3
9195
75599
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
3.7
18.3
81
195
R06.0
ICD-10 Finland
Dyspnoea
1.2
18.2
4733
37135
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.3
18.2
1737
12320
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
5.3
18.2
56
94
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
1.7
18.2
394
2097
CGG60
NOMESCO Finland
Reinforcement of sclera using graft
41.0
18.1
23
5
A04
ICPC
Weakness/tiredness general
1.2
18.1
2174
15855
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.1
18.0
9743
80457
H81
ICPC
Excessive ear wax
1.2
18.0
3068
23200
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.5
17.9
622
3728
UDC00
NOMESCO Finland
Ear microscopy
1.3
17.9
1173
7899
H03AA01
ATC
levothyroxine sodium; systemic
1.2
17.6
4267
33282
C09CA06
ATC
candesartan; oral
1.2
17.6
3816
29493
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.2
17.4
3181
24207
J02AC01
ATC
fluconazole; systemic
1.1
17.4
6658
53723
R44
ICPC
Respiratory, Preventive immunization/medic
1.8
17.3
295
1461
G04BD12
ATC
mirabegron; oral
1.3
17.3
1889
13626
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.2
17.2
1993
14469
L03
ICPC
Low back symptom/complaint
1.2
17.2
4051
31510
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.3
17.2
1274
8739
I49.5
ICD-10 Finland
Sick sinus syndrome
1.4
17.1
729
4555
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
17.1
2411
17888
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
2.6
17.1
126
433
H18.2
ICD-10 Finland
Other corneal oedema
4.8
17.1
57
105
CFW10
NOMESCO Finland
Conjunctival manipulation with a needle (needling)
+∞
16.9
17
*
CA1TM
NOMESCO Finland
Calculation of intraocular lens power
1.8
16.9
300
1505
SPAT1014
SPAT
Treatment of eyes
1.8
16.9
311
1578
S82
ICPC
Naevus/mole
1.2
16.8
1932
14020
SPAT1211
SPAT
Application of soft bandage
1.3
16.7
1537
10852
3656
FHL
Combined cataract glaucoma surgery
160.3
16.7
18
*
CHC10
NOMESCO Finland
Peripheral iridectomy
20.3
16.6
25
11
M54.5
ICD-10 Finland
Low back pain
1.1
16.4
5545
44317
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
2.3
16.4
156
613
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.2
16.4
2870
21746
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
16.4
4945
39202
S06.0
ICD-10 Finland
Concussion
1.3
16.3
1573
11173
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
2.5
16.3
132
479
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
4.6
16.3
57
111
S05.1
ICD-10 Finland
Contusion of eyeball and orbital tissues
2.0
16.2
203
899
S97
ICPC
Chronic ulcer skin
1.4
16.2
948
6270
C07AB07
ATC
bisoprolol; oral
1.1
16.2
10142
84299
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
16.1
2883
21889
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
1.6
16.0
399
2210
SPAT1131
SPAT
Colonoscopy
1.5
16.0
549
3285
37599
ICD-8 Finland
Glaucoma, Unspecified
+∞
15.9
16
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.3
15.9
1605
11463
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.4
15.9
960
6382
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
3.5
15.9
74
187
C02AC05
ATC
moxonidine; oral
1.4
15.9
785
5048
SAA03
NOMESCO Finland
Extended examination of mouth
1.1
15.8
6166
49743
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.2
15.8
1857
13504
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.3
15.8
1745
12597
A10AA03
ATC
NA
2.2
15.7
159
643
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.6
15.7
118
411
165
Kela drug reimbursment
Preservative-free combination of bimatoprost and timolol
151.4
15.7
17
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.3
15.7
1292
8988
G03CB01
ATC
dienestrol; oral, vaginal
1.5
15.7
511
3020
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
2.6
15.7
118
412
L13
ICPC
Hip symptom/complaint
1.2
15.6
2889
22000
C09AA02
ATC
enalapril; systemic
1.2
15.6
4046
31699
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.5
15.4
576
3507
SPAT1216
SPAT
Assessment of functional ability
1.2
15.4
2980
22783
R06AE07
ATC
cetirizine; oral
1.1
15.4
7483
61209
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
1.7
15.4
296
1526
M01AC06
ATC
meloxicam; systemic, rectal
1.1
15.3
6888
56062
L28
ICPC
Limited function/disability (L)
1.2
15.3
2988
22857
CJF20
NOMESCO Finland
Removal of artificial lens
6.7
15.3
39
52
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.3
15.2
1132
7766
M05BA04
ATC
alendronic acid; oral
1.3
15.2
1593
11429
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
15.2
2772
21075
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
3.7
15.2
66
158
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
1.4
15.1
793
5152
L86
ICPC
Back syndrome with radiating pain
1.4
15.1
868
5724
WX400
NOMESCO Finland
Inhalation anesthesy
1.5
15.1
563
3428
XCH00
SPAT
NA
21.8
15.0
22
9
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.3
15.0
1198
8304
R4180
NOMESCO Finland
Podiatric therapy
2.1
15.0
170
723
3623C
ICD-9 Finland
Other retinal disorders, Retinal vascular occlusion[OCCLUSIO VENAE CENTRALIS RETINAE]
18.6
14.9
23
11
U02
ICPC
Urinary frequency/urgency
1.2
14.9
2185
16270
SPAT1081
SPAT
Cardiorespiratory global assessment
1.3
14.9
1038
7058
L60.0
ICD-10 Finland
Ingrowing nail
1.4
14.8
623
3885
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
2.6
14.8
107
364
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
3.1
14.8
84
245
N05CF01
ATC
zopiclone; oral
1.1
14.6
6376
51758
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
23.4
14.6
21
8
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
1.4
14.6
756
4901
H15.1
ICD-10 Finland
Episcleritis
2.0
14.6
197
900
H35.37
ICD-10 Finland
Macular holes
1.8
14.6
237
1158
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.4
14.5
794
5196
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
2.7
14.5
98
320
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
1.5
14.5
479
2843
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.3
14.5
1248
8739
VALMI
NOMESCO Finland
NA
1.2
14.4
3615
28226
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
2.3
14.4
131
505
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.4
14.4
773
5040
H44.2
ICD-10 Finland
Degenerative myopia
4.5
14.4
51
101
D82
ICPC
Teeth/gum disease
1.1
14.3
5276
42352
H44.1
ICD-10 Finland
Other endophthalmitis
6.1
14.3
39
57
L08
ICPC
Shoulder symptom/complaint
1.2
14.3
3273
25366
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
5.5
14.2
42
68
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
3.4
14.2
69
181
H35.9
ICD-10 Finland
Retinal disorder, unspecified
2.7
14.2
97
321
N30.0
ICD-10 Finland
Acute cystitis
1.2
14.2
2343
17646
CHB15
NOMESCO Finland
Puncture of anterior chamber of eye with replacement of aqueous
6.7
14.1
36
48
L04AA06
ATC
mycophenolic acid; systemic
1.8
14.1
238
1177
H44.0
ICD-10 Finland
Purulent endophthalmitis
5.0
14.1
45
80
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.1
14.1
6094
49429
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
4.2
14.1
54
116
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.8
14.0
1400
15276
K02.1
ICD-10 Finland
Caries of dentine
1.1
14.0
9469
78821
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
5.9
14.0
39
59
S01XA18
ATC
ciclosporin; ophthalmic
2.6
13.9
99
335
H54.5
ICD-10 Finland
Severe visual impairment, monocular
2.9
13.9
86
267
WX704
NOMESCO Finland
Intubation
1.3
13.9
1078
7445
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.1
13.8
7545
62046
SLT
NOMESCO Finland
NA
133.6
13.8
15
*
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.5
13.8
437
2570
F05
ICPC
Visual disturbance other
1.5
13.8
411
2384
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
13.8
4071
32174
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
4.5
13.7
49
98
0147
NOMESCO Finland
NA
14.6
13.7
23
14
H33.2
ICD-10 Finland
Serous retinal detachment
3.5
13.7
64
163
H25.2
ICD-10 Finland
Senile cataract, morgagnian type
2.5
13.7
111
403
SPAT1058
SPAT
PEF monitoring instruction
1.3
13.7
1364
9724
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
3.5
13.7
63
159
R05
ICD-10 Finland
Cough
1.2
13.7
3296
25651
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.2
13.6
1559
11300
G44.2
ICD-10 Finland
Tension-type headache
1.2
13.6
1905
14117
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
11.7
13.6
25
19
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
2.7
13.6
92
301
R55
ICD-10 Finland
Syncope and collapse
1.2
13.6
1929
14316
S29
ICPC
Skin symptom/complaint other
1.2
13.5
2890
22263
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.1
13.5
8408
69624
R03AC02
ATC
salbutamol; inhalant
1.1
13.4
9597
80064
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
13.7
13.4
23
15
21899
ICD-8 Finland
Uterine fibroma
1.4
13.4
757
4984
H47.2
ICD-10 Finland
Optic atrophy
2.9
13.3
79
240
H18.4
ICD-10 Finland
Corneal degeneration
2.9
13.3
82
254
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.4
13.3
672
4344
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
3.6
13.3
59
145
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.2
13.2
3795
29917
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.1
13.2
4385
34932
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.2
13.2
1610
11758
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.1
13.2
4456
35542
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.3
13.1
1182
8328
M45
ICD-10 Finland
Ankylosing spondylitis
1.7
13.1
276
1466
CBA10
NOMESCO Finland
Biopsy of eyelid
2.0
13.1
159
701
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
2.2
13.0
125
497
H17.8
ICD-10 Finland
Other corneal scars and opacities
3.6
13.0
58
143
3793C
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]
2.7
13.0
89
295
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.3
13.0
1261
8966
XQ848
NOMESCO Finland
Dermatological photography
1.5
13.0
396
2313
A02BC01
ATC
omeprazole; systemic
1.1
13.0
5297
42767
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
4.7
13.0
44
84
-69
ICPC
Other reason for encounter NEC
1.4
13.0
625
4007
S01EB03
ATC
ecothiopate; ophthalmic
+∞
12.9
13
*
H221, M084
ICD-10 Finland
NA
+∞
12.9
13
*
3653A
ICD-9 Finland
Glaucoma, Corticosteroid-induced glaucoma
+∞
12.9
13
*
CHB50
NOMESCO Finland
Trabeculotomy
+∞
12.9
13
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
2.4
12.9
112
422
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
12.9
2469
18840
H35.8
ICD-10 Finland
Other specified retinal disorders
2.7
12.9
90
303
CKA10
NOMESCO Finland
Biopsy of vitreous body
4.9
12.9
42
77
Z97.4
ICD-10 Finland
Presence of external hearing-aid
1.3
12.8
846
5704
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.1
12.8
3964
31407
3792A
ICD-9 Finland
Other disorders of eye, Disorders of vitreous body
6.5
12.8
33
45
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.3
12.8
994
6867
37403
ICD-8 Finland
Cataract, Complicata
6.0
12.8
35
52
J01MA02
ATC
ciprofloxacin; systemic
1.1
12.8
7581
62560
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.3
12.7
1256
8948
CBJ30
NOMESCO Finland
Plastic repair of levator aponeurosis of eyelid
2.6
12.7
93
322
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.4
12.7
740
4894
Z94.0
ICD-10 Finland
Kidney transplant status
2.0
12.7
154
678
C09AA05
ATC
ramipril; oral
1.1
12.7
4959
39918
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.2
12.7
1495
10875
H33.1
ICD-10 Finland
Retinoschisis and retinal cysts
2.4
12.6
108
406
CJF00
NOMESCO Finland
Secondary implantation of artificial lens in anterior chamber
5.0
12.6
40
71
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
12.6
3220
25159
A10BA02
ATC
metformin; oral
1.1
12.6
5397
43696
J01AA02
ATC
doxycycline; systemic
1.1
12.5
16284
139914
CKD45
NOMESCO Finland
Endocryotherapy of retina
10.7
12.5
24
20
196
Kela drug reimbursment
Paricalcitol and cinacalcet
2.8
12.5
79
251
CKC65
NOMESCO Finland
Removal of buckling implant from sclera
6.3
12.5
33
47
H84
ICPC
Presbyacusis
1.4
12.4
595
3809
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
12.3
2927
22735
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.4
12.3
698
4597
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
1.7
12.3
246
1287
XQ845
NOMESCO Finland
Dermatoscopy
1.8
12.3
213
1065
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.3
12.3
1227
8759
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.3
12.3
879
6003
N05BA04
ATC
oxazepam; oral
1.1
12.3
4323
34557
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
1.5
12.2
426
2565
J01FF01
ATC
clindamycin; systemic
1.1
12.2
4717
37932
R01AD12
ATC
fluticasone furoate; nasal
1.1
12.2
4219
33685
M05BX04
ATC
denosumab; parenteral
1.3
12.2
858
5848
S01GX08
ATC
ketotifen; ophthalmic
1.5
12.1
450
2744
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
12.1
3089
24123
H50.1
ICD-10 Finland
Divergent concomitant strabismus
2.4
12.1
105
398
M70.6
ICD-10 Finland
Trochanteric bursitis
1.2
12.1
2059
15544
L88
ICPC
Rheumatoid/seropositive arthritis
1.4
12.1
575
3680
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.1
12.1
4769
38397
S05.0
ICD-10 Finland
Injury of conjunctiva and corneal abrasion without mention of foreign body
1.7
12.0
252
1336
C10AA03
ATC
pravastatin; oral
1.2
12.0
1311
9454
CJF10
NOMESCO Finland
Secondary implantation of artificial lens in posterior chamber
4.5
12.0
42
83
C07AB02
ATC
metoprolol; systemic
1.1
12.0
4280
34228
Z49.1
ICD-10 Finland
Extracorporeal dialysis
1.8
12.0
205
1021
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
2.4
12.0
100
370
K86
ICPC
Hypertension uncomplicated
1.2
12.0
2146
16281
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.2
12.0
2070
15654
37513
ICD-8 Finland
Glaucoma, Chronicum pigmentosum
+∞
11.9
12
*
CHD60
NOMESCO Finland
Deep sclerectomy without implant
62.5
11.9
14
*
H10.4
ICD-10 Finland
Chronic conjunctivitis
2.2
11.9
126
523
H34.9
ICD-10 Finland
Retinal vascular occlusion, unspecified
3.8
11.9
50
118
CHD20
NOMESCO Finland
Posterior sclerotomy
28.5
11.8
16
5
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
11.8
2456
18867
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
1.3
11.8
1195
8546
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.4
11.8
536
3404
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.2
11.7
1583
11682
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
2.4
11.7
98
363
WZA90
NOMESCO Finland
Other doctors statement
1.1
11.7
3576
28301
127
Kela drug reimbursment
Transplant complication
1.8
11.7
198
985
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.2
11.7
1447
10588
H19.8*E85.80
ICD-10 Finland
Reticular keratitis in Meretoja's patients
8.6
11.7
25
26
H31.3
ICD-10 Finland
Choroidal haemorrhage and rupture
6.1
11.6
31
45
R06AX27
ATC
desloratadine; oral
1.1
11.6
3794
30169
H29
ICPC
Ear symptom/complaint other
1.2
11.5
1656
12297
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.4
11.5
631
4138
H34.2
ICD-10 Finland
Other retinal artery occlusions
2.3
11.5
109
432
CBB30
NOMESCO Finland
Excision of lesion of eyelid
1.4
11.5
462
2862
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.4
11.5
554
3553
H35.7
ICD-10 Finland
Separation of retinal layers
2.0
11.4
135
588
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
1.6
11.4
327
1884
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.3
11.4
1171
8385
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.1
11.4
9585
80415
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
2.2
11.4
115
469
Z37.0
ICD-10 Finland
Single live birth
0.6
11.3
186
2700
R01AD08
ATC
fluticasone; nasal
1.1
11.3
4515
36358
H3602, E103
ICD-10 Finland
NA
4.1
11.3
43
93
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
1.5
11.2
342
1999
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.2
11.2
1392
10181
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
1.7
11.2
237
1260
H02.3
ICD-10 Finland
Blepharochalasis
1.3
11.2
1057
7489
R60.0
ICD-10 Finland
Localized oedema
1.2
11.2
1923
14533
SPAT1016
SPAT
Examination of vision
1.3
11.1
679
4528
DAX08
NOMESCO Finland
Fitting of hearing aid
1.3
11.1
725
4888
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
2.6
11.1
78
265
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
3.0
11.1
63
186
S01GX05
ATC
lodoxamide; ophthalmic
1.8
11.1
198
1002
E85.80
ICD-10 Finland
Meretoja sick
6.6
11.0
28
38
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.1
11.0
4074
32641
-31
ICPC
Medical examin/health eval partial
1.3
11.0
1127
8069
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.8
11.0
618
7214
3651E
ICD-9 Finland
Glaucoma, Open-angle glaucoma[GLAUCOMA INFANTILE SEU JUVENILE]
+∞
11.0
11
*
3704
FHL
Iridectomy
+∞
11.0
11
*
S01EXXX
ATC
NA
+∞
11.0
11
*
CDC40
NOMESCO Finland
Evisceration of eye with insertion of prosthesis
13.0
10.9
19
13
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.3
10.9
808
5547
CHF12
NOMESCO Finland
Endoscopic laser coagulation of ciliary body
106.9
10.9
12
*
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
1.5
10.9
324
1887
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.3
10.8
908
6346
SPAT1285
SPAT
Provision of consultation response
1.3
10.8
851
5894
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.1
10.8
3357
26592
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.3
10.7
1019
7231
R01AD01
ATC
beclometasone; nasal
1.2
10.7
2346
18099
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
2.1
10.7
118
501
K78
ICPC
Atrial fibrillation/flutter
1.2
10.7
1431
10553
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.3
10.7
809
5571
G03CC04
ATC
estrone; systemic
1.4
10.7
579
3792
A01
ICPC
Pain general/multiple sites
1.2
10.7
1197
8662
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.2
10.6
1982
15082
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.2
10.6
1992
15168
C09CA03
ATC
valsartan; oral
1.2
10.6
1514
11236
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
2.5
10.6
79
278
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.1
10.6
8055
67171
CK2K4
NOMESCO Finland
Red-free imaging of ocular fundus
3.9
10.6
42
95
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
2.5
10.5
78
273
S01FA06
ATC
tropicamide; ophthalmic
4.0
10.5
41
91
R02
ICPC
Shortness of breath/dyspnoea
1.2
10.5
1998
15234
N06AX21
ATC
duloxetine; oral
1.2
10.5
1509
11210
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
1.7
10.5
195
1000
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.2
10.5
1948
14822
H28.0
ICD-10 Finland
Diabetic cataract
5.6
10.5
30
48
H35.4
ICD-10 Finland
Peripheral retinal degeneration
2.1
10.5
119
513
NF1AA
NOMESCO Finland
Hip X-ray examination
1.2
10.5
1523
11328
M01AH01
ATC
celecoxib; oral (coxibs)
1.1
10.5
3229
25558
N18.8
ICD-10 Finland
Other chronic renal failure
1.4
10.4
446
2802
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
3.5
10.4
47
119
H01
ICPC
Ear pain/earache
1.2
10.4
1379
10164
R03BA08
ATC
ciclesonide; inhalant
1.2
10.4
1160
8394
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.5
10.3
360
2171
3002
NOMESCO Finland
NA
38.6
10.3
13
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
1.5
10.3
386
2363
3649
FHL
Other measure in this category
11.3
10.3
19
15
CGF35
NOMESCO Finland
Repair of cornea using graft
8.5
10.3
22
23
Z00.0
ICD-10 Finland
General medical examination
1.1
10.3
3073
24260
N0830, E102
ICD-10 Finland
NA
5.9
10.3
28
42
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.4
10.3
86
321
H10.5
ICD-10 Finland
Blepharoconjunctivitis
1.7
10.3
209
1102
D06BX01
ATC
metronidazole; topical
1.2
10.3
1583
11841
G03FA01
ATC
norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
1.2
10.2
2307
17838
H04.0
ICD-10 Finland
Dacryoadenitis
3.1
10.2
54
154
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.3
10.2
1007
7179
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.1
10.2
3966
31862
D07AA02
ATC
hydrocortisone; topical
1.2
10.2
1961
14966
C10AX09
ATC
ezetimibe; oral
1.2
10.2
1852
14065
KMAK
NOMESCO Finland
NA
1.1
10.2
8585
71906
SPAT1377
SPAT
Polysomnography
1.4
10.2
441
2779
3747
FHL
Combined ablation and vitreous surgery with coagulation
5.8
10.1
28
43
CWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in eye and adjacent structures
24.9
10.1
14
5
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
8.2
10.1
22
24
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.3
10.0
1005
7179
3744
FHL
Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)
3.7
10.0
42
100
R05
ICPC
Cough
1.1
10.0
3627
29009
H02.1
ICD-10 Finland
Ectropion of eyelid
1.7
10.0
187
964
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
3.2
10.0
52
147
S94
ICPC
Ingrowing nail
1.7
10.0
218
1175
-1
SPAT
NA
1.4
10.0
437
2760
H221, M083
ICD-10 Finland
NA
+∞
10.0
10
*
N07CA01
ATC
betahistine; oral
1.2
9.9
1267
9301
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.1
9.9
4211
34006
74420
ICD-8 Finland
Congenital anomalies of eye, Buphthalmus (glaucoma)
98.0
9.9
11
*
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
3.6
9.9
44
110
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.3
9.9
913
6459
L14
ICPC
Leg/thigh symptom/complaint
1.2
9.9
1152
8373
N04BC05
ATC
pramipexole; oral
1.2
9.9
1220
8926
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
1.3
9.8
680
4627
H02AB02
ATC
dexamethasone; systemic
0.8
9.8
1246
13284
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.2
9.8
1743
13206
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
9.8
337
4229
C01DA14
ATC
isosorbide mononitrate; oral
1.1
9.8
3232
25687
NH3EA
NOMESCO Finland
Feet X-ray examination with load
1.6
9.8
276
1588
XF400
NOMESCO Finland
ECG with 12 standard connections
0.9
9.8
2404
24300
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.2
9.8
1799
13675
V03AE03
ATC
lanthanum carbonate; oral
2.9
9.8
58
179
E000001
ATC
NA
1.1
9.8
3274
26048
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.2
9.7
2541
19870
G03DB02
ATC
megestrol; oral (pregnadien derivatives)
1.3
9.7
710
4871
H54.6
ICD-10 Finland
Moderate visual impairment, monocular
3.0
9.7
56
169
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.1
9.7
6769
56148
B01AC04
ATC
clopidogrel; oral
1.1
9.7
3004
23781
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.3
9.7
687
4692
T85.3
ICD-10 Finland
Mechanical complication of other ocular prosthetic devices, implants and grafts
14.3
9.6
16
10
CJG40
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial scleral fixed lens in posterior chamber and iridectomy or iridotomy
7.5
9.6
22
26
K59.09
ICD-10 Finland
Constipation, unspecified
1.3
9.6
981
7024
C08CA02
ATC
felodipine; oral
1.2
9.6
1759
13369
1LA05
NOMESCO Finland
NA
2.3
9.6
84
322
A03FA02
ATC
cisapride; oral, rectal
1.2
9.6
1367
10154
130
Kela drug reimbursment
Malignant tumour
0.8
9.5
1005
10907
SPAT1210
SPAT
Application of cast or individual aid
1.3
9.5
598
4012
C03AA03
ATC
hydrochlorothiazide; oral
1.2
9.5
1815
13839
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.4
9.5
454
2913
L04AB04
ATC
adalimumab; parenteral
1.6
9.5
210
1138
S08
ICPC
Skin colour change
1.3
9.5
765
5319
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.7
9.5
227
3034
WX725
NOMESCO Finland
Noninvasive ventilation
1.3
9.5
655
4458
S19
ICPC
Skin injury other
1.3
9.4
567
3779
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.5
9.4
76
1323
J45.9
ICD-10 Finland
Asthma, unspecified
1.1
9.4
2951
23374
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
3.5
9.4
42
106
R09
ICPC
Sinus symptom/complaint
1.3
9.4
914
6508
T08
ICPC
Weight loss
1.7
9.3
193
1025
H05BX01
ATC
cinacalcet; oral
2.2
9.3
91
369
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.3
9.3
655
4470
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
3.5
9.3
42
107
L01
ICPC
Neck symptom/complaint
1.2
9.3
2022
15591
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
1.8
9.3
162
819
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.3
9.3
883
6272
Z83.5
ICD-10 Finland
Family history of eye and ear disorders
4.5
9.2
32
64
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
3.0
9.2
53
159
A44
ICPC
General and Unspecified, Preventive immunization/medic
1.2
9.2
1128
8241
H35.6
ICD-10 Finland
Retinal haemorrhage
2.0
9.2
107
466
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
3.0
9.2
51
151
R11
ICD-10 Finland
Nausea and vomiting
1.2
9.2
1185
8705
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.2
9.2
1263
9344
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.2
9.2
1057
7676
G03FB06
ATC
medroxyprogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.2
9.2
1612
12205
B01AB05
ATC
enoxaparin; parenteral
1.1
9.2
5740
47328
U01
ICPC
Dysuria/painful urination
1.2
9.2
1048
7603
R03BA05
ATC
fluticasone; inhalant
1.1
9.2
2832
22410
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
2.1
9.1
104
449
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
4.3
9.1
33
69
M05BA07
ATC
risedronic acid; oral
1.3
9.1
545
3630
171
Kela drug reimbursment
Degludekinsuliini
3.2
9.1
46
128
H53.2
ICD-10 Finland
Diplopia
1.4
9.1
437
2810
Z01.2
ICD-10 Finland
Dental examination
1.1
9.1
6561
54478
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.4
9.1
75
280
G45.3
ICD-10 Finland
Amaurosis fugax
1.5
9.0
295
1758
J05AB11
ATC
valaciclovir; oral
1.2
9.0
2017
15580
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.1
9.0
5746
47411
Z71.8
ICD-10 Finland
Other specified counselling
1.1
9.0
3608
29017
J01FA10
ATC
azithromycin; systemic
1.1
9.0
9847
83293
K30
ICD-10 Finland
Functional dyspepsia
1.2
9.0
1565
11838
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.2
9.0
1011
7322
R06AE09
ATC
levocetirizine; oral
1.2
9.0
1963
15139
74439
ICD-8 Finland
Congenital anomalies of eye, Cataracta NUD
11.9
9.0
16
12
3654A
ICD-9 Finland
Glaucoma associated with congenital anomalies, dystrophies and systemic syndromes
+∞
9.0
9
*
H3603, H405
ICD-10 Finland
NA
+∞
9.0
9
*
7432A
ICD-9 Finland
Congenital anomalies of eye, Buphthalmos[GLAUCOMA CONGENITUM]
89.1
9.0
10
*
S21
ICPC
Skin texture symptom/complaint
1.2
9.0
2010
15535
R51.81
ICD-10 Finland
Facial pain NOS
1.5
9.0
285
1690
A06AD11
ATC
lactulose; oral
1.1
9.0
2737
21639
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
7.7
8.9
20
23
XKD00
NOMESCO Finland
Uroflowmetry
1.1
8.9
2930
23274
R01BA52
ATC
pseudoephedrine, combinations; oral
1.1
8.9
5176
42500
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
3.0
8.9
51
153
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
2.7
8.9
60
199
C10AA04
ATC
fluvastatin; oral
1.2
8.9
1644
12505
SPAT1234
SPAT
Support of social functional capacity
1.3
8.9
819
5795
R96
ICPC
Asthma
1.2
8.9
1330
9923
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
0.4
8.9
45
913
V03AE02
ATC
sevelamer; oral
2.3
8.9
75
285
CD1AE
NOMESCO Finland
Other special ultrasound examination of the eye
26.7
8.9
12
*
A11CC03
ATC
alfacalcidol; systemic
1.5
8.9
338
2080
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.3
8.9
665
4580
NHQ40
NOMESCO Finland
Amputation of toe
1.5
8.8
262
1527
M01AH02
ATC
rofecoxib; oral
1.2
8.8
2396
18785
SPAT1202
SPAT
Intra-articular injection
1.3
8.8
535
3571
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.2
8.8
2237
17455
E03
ICD-10 Finland
Other hypothyroidism
1.3
8.8
848
6033
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
15.6
8.8
14
8
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
1.5
8.8
260
1517
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
2.6
8.8
63
217
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
1.6
8.8
214
1191
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
5.8
8.8
24
37
Y0291
ICD-8 Finland
Examination of the nervous system and sensory organs, Eye
5.8
8.8
24
37
H04.4
ICD-10 Finland
Chronic inflammation of lacrimal passages
2.4
8.7
68
248
ZZL00
NOMESCO Finland
Free graft of amniotic membrane
7.4
8.7
20
24
M02AA10
ATC
ketoprofen; topical
1.1
8.7
2736
21668
UKC02
NOMESCO Finland
Cystoscopy
1.1
8.7
3028
24147
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.2
8.7
1072
7844
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
1.6
8.7
229
1302
S01XA02
ATC
retinol; ophthalmic
2.1
8.6
96
413
M54.4
ICD-10 Finland
Lumbago with sciatica
1.1
8.6
2450
19274
E000006
ATC
NA
1.2
8.6
1085
7959
Z97.0
ICD-10 Finland
Presence of artificial eye
6.3
8.6
22
31
S22
ICPC
Nail symptom/complaint
1.3
8.6
863
6173
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
1.3
8.6
597
4073
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.3
8.5
823
5860
Q12.0
ICD-10 Finland
Congenital cataract
5.3
8.5
25
42
CKD00
NOMESCO Finland
Puncture of vitreous body for decompression
8.4
8.5
18
19
37703
ICD-8 Finland
Other diseases of retina and optic nerve, Thrombosis venae centralis retinae
8.4
8.5
18
19
3625
FHL
Extracapsular nuclear cataract removal
8.4
8.5
18
19
N06AA09
ATC
amitriptyline; systemic
1.2
8.5
1700
13018
M01AX17
ATC
nimesulide; oral
1.1
8.5
4654
38093
L12
ICPC
Hand/finger symptom/complaint
1.2
8.5
2102
16369
SPAT1252
SPAT
Overall medication plan or its review
1.2
8.5
1192
8840
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.2
8.5
2133
16634
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.2
8.4
898
6468
SPAT1139
SPAT
Nutrition survey
1.4
8.4
481
3183
37404
ICD-8 Finland
Cataract, Secundaria
6.1
8.4
22
32
A10BX01
ATC
guar gum; systemic
1.3
8.4
672
4670
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
1.5
8.4
287
1729
N06DX01
ATC
memantine; oral
1.2
8.4
1075
7902
WX199
NOMESCO Finland
Other local analgesia
1.4
8.4
388
2478
TPH04
NOMESCO Finland
Cathetrisation of vein
1.1
8.4
3627
29301
CHB60
NOMESCO Finland
Anterior synechiolysis
16.5
8.4
13
7
B05DB
ATC
Hypertonic solutions
2.1
8.3
86
357
B05DA
ATC
Isotonic solutions
2.0
8.3
98
431
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
8.9
8.3
17
17
AN1
HP
Coronary angiography
1.2
8.3
2220
17390
H46
ICD-10 Finland
Optic neuritis
2.1
8.3
91
390
M54.6
ICD-10 Finland
Pain in thoracic spine
1.3
8.2
844
6049
N30.9
ICD-10 Finland
Cystitis, unspecified
1.3
8.2
829
5934
104
Kela drug reimbursment
Thyroid insufficiency
1.2
8.2
1193
8875
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.4
8.2
321
1987
137
Kela drug reimbursment
Uraemia requiring dialysis
1.9
8.2
120
573
H35.29
ICD-10 Finland
Other proliferative retinopathy
5.5
8.2
23
37
H22.0*B02.3
ICD-10 Finland
Zoster iridocyclitis
3.9
8.2
32
73
SPAT1360
SPAT
Extensive global examination
1.2
8.1
1231
9196
F16
ICPC
Eyelid symptom/complaint
1.3
8.1
642
4457
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
1.7
8.1
150
774
N02AJ06
ATC
codeine and paracetamol; systemic
1.1
8.1
6230
51819
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.2
8.1
1812
13997
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.1
8.1
2909
23235
CBJ10
NOMESCO Finland
Fascia plate sling or synthetic material for ptosis correction
6.6
8.1
20
27
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.4
8.1
388
2495
F13
ICPC
Eye sensation abnormal
1.4
8.1
349
2201
CH2S4
NOMESCO Finland
Photography of iris
5.8
8.1
22
34
D07AC13
ATC
mometasone; topical
1.1
8.1
4955
40779
L04AX01
ATC
azathioprine; systemic
1.3
8.1
564
3852
M01AX01
ATC
nabumetone; oral
1.3
8.1
692
4857
B01AF02
ATC
apixaban; oral
1.2
8.1
1733
13352
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
1.7
8.0
158
830
H18.6
ICD-10 Finland
Keratoconus
2.3
8.0
74
293
S01EB51
ATC
pilocarpine, combinations; ophthalmic
80.2
8.0
9
*
DFF00
NOMESCO Finland
Pure tone audiometry
1.2
8.0
1452
11030
CHB65
NOMESCO Finland
Posterior synechiolysis
14.5
8.0
13
8
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.2
8.0
940
6848
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.2
8.0
924
6720
SPAT1281
SPAT
Other administrative function
1.2
7.9
1182
8819
R07.2
ICD-10 Finland
Precordial pain
1.5
7.9
300
1848
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.2
7.9
826
5938
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
5.6
7.9
22
35
H61.2
ICD-10 Finland
Impacted cerumen
1.2
7.9
868
6277
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
1.3
7.9
509
3437
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.2
7.9
1267
9524
XJH00
NOMESCO Finland
Transanal ultrasonography
1.2
7.8
1086
8046
L16
ICPC
Ankle symptom/complaint
1.2
7.8
1432
10885
CBB10
NOMESCO Finland
Excision of redundant skin of eyelid
1.4
7.8
391
2532
TQW80
NOMESCO Finland
Local dermatologic skincare
1.4
7.8
369
2370
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
1.4
7.8
317
1977
S01GX02
ATC
levocabastine; ophthalmic
1.3
7.8
760
5418
H16.2
ICD-10 Finland
Keratoconjunctivitis
2.1
7.8
83
352
N083, E102
ICD-10 Finland
NA
4.4
7.8
27
55
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.2
7.8
2034
15903
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.8
200
1128
A10BB12
ATC
glimepiride; oral
1.2
7.7
1307
9865
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.2
7.7
979
7185
I50.9
ICD-10 Finland
Heart failure, unspecified
1.1
7.7
2646
21075
H52.3
ICD-10 Finland
Anisometropia and aniseikonia
2.0
7.7
98
447
CJF50
NOMESCO Finland
Removal and implantation of artificial lens in posterior chamber
5.7
7.6
21
33
36409
ICD-8 Finland
Iritis, Unspecified
5.7
7.6
21
33
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.3
7.6
607
4220
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.3
7.6
702
4976
37100
ICD-8 Finland
Corneal opacity, Cicatrix (nubecula, macula, leucoma) cornea
8.4
7.6
16
17
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
2.3
7.6
68
266
9271
FHL
Hallux surgery
1.4
7.6
375
2427
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
2.1
7.6
79
333
S01BC01
ATC
indometacin; ophthalmic
4.2
7.5
27
57
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
1.3
7.5
580
4014
K07
ICPC
Swollen ankles/oedema
1.3
7.5
699
4955
D01
ICPC
Abdominal pain/cramps general
1.2
7.5
1413
10768
EBA10
NOMESCO Finland
Surgical removal of tooth
1.2
7.5
1257
9480
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.3
7.5
506
3440
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.2
7.5
1104
8232
H3603, H431
ICD-10 Finland
NA
10.4
7.5
14
12
I95.1
ICD-10 Finland
Orthostatic hypotension
1.3
7.5
547
3763
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
1.2
7.5
1047
7771
M14.6
ICD-10 Finland
Neuropathic arthropathy
3.4
7.4
34
89
N01
ICPC
Headache
1.2
7.4
1099
8197
F06.7
ICD-10 Finland
Mild cognitive disorder
1.4
7.4
401
2636
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
1.6
7.4
172
950
C09BA02
ATC
enalapril and diuretics; systemic
1.2
7.4
1498
11487
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
3.9
7.4
29
67
M03BX02
ATC
tizanidine; oral
1.1
7.3
11003
93983
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
1.8
7.3
113
551
JN3AD
NOMESCO Finland
Abdominal CT examination
1.2
7.3
1160
8708
SXA05
NOMESCO Finland
NA
1.8
7.3
124
622
H36.04
ICD-10 Finland
Severe diabetic ophthalmopathy
11.6
7.3
13
10
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.1
7.3
2706
21650
CG2Z4
NOMESCO Finland
Specialised imaging of cornea
3.2
7.3
36
100
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.3
7.3
521
3572
HAMTE
NOMESCO Finland
NA
1.9
7.3
103
489
TK800
NOMESCO Finland
Hemodialysis
1.4
7.3
293
1828
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.2
7.3
1475
11312
D06BB10
ATC
imiquimod; topical
1.3
7.2
640
4511
H54.7
ICD-10 Finland
Unspecified visual loss
1.9
7.2
98
456
MAX99
NOMESCO Finland
Assistance to normal delivery
0.6
7.2
137
1914
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.1
7.2
6678
55950
K03.64
ICD-10 Finland
Dental calculus supragingival
1.1
7.2
3910
31957
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.1
7.2
2429
19321
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
1.7
7.2
134
692
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.1
7.2
4441
36533
TPH07
NOMESCO Finland
Cathetrisation of artery
1.2
7.2
1697
13167
H15.0
ICD-10 Finland
Scleritis
2.5
7.2
52
184
CJE25
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber and iridectomy or iridotomy
9.6
7.2
14
13
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.5
7.2
43
822
H47.3
ICD-10 Finland
Other disorders of optic disc
2.7
7.2
46
150
3102
FHL
Enucleation
13.4
7.2
12
8
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.2
7.2
1434
10982
CKC75
NOMESCO Finland
Removal of cerclage from sclera
6.9
7.2
17
22
J45.1
ICD-10 Finland
Nonallergic asthma
1.2
7.2
1034
7696
U04
ICPC
Incontinence urine
1.3
7.2
710
5075
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.1
7.2
5602
46600
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.5
7.1
41
791
L15
ICPC
Knee symptom/complaint
1.1
7.1
3498
28439
S01FB01
ATC
phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)
4.9
7.1
22
40
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
2.1
7.1
80
347
R03DC03
ATC
montelukast; oral
1.1
7.1
2293
18189
TCG30
NOMESCO Finland
Imaging of anterior and posterior part of cornea
3.8
7.1
28
65
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.4
7.1
387
2550
B01AA03
ATC
warfarin; systemic
1.1
7.1
4078
33436
L04AD01
ATC
ciclosporin; systemic
1.5
7.1
223
1323
3745
FHL
Hard membrane girding, cerclage with coagulation
3.3
7.1
34
93
3705
FHL
Iridectomy or iridotomy using a laser under general anesthesia
71.3
7.1
8
*
R04.0
ICD-10 Finland
Epistaxis
1.2
7.1
1190
8987
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
1.7
7.0
141
746
CKD75
NOMESCO Finland
Retinotomy
10.5
7.0
13
11
E10.09
ICD-10 Finland
Insulin-dependent diabetes mellitus - With coma
5.1
7.0
21
37
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.9
7.0
1404
14400
WX402
NOMESCO Finland
General anaesthesia
1.1
7.0
2414
19230
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
1.9
7.0
92
425
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.8
7.0
352
4157
CHF30
NOMESCO Finland
Cyclodialysis
+∞
7.0
7
*
CG3X4
NOMESCO Finland
Optical coherence tomography (OCT) of sclera
+∞
7.0
7
*
A46
ICD-10 Finland
Erysipelas
1.1
7.0
2403
19145
N02CA52
ATC
ergotamine, combinations excl. psycholeptics; oral
1.5
7.0
234
1411
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.4
7.0
270
1673
C09DA06
ATC
candesartan and diuretics; oral
1.2
6.9
1172
8848
K25
ICPC
Fear of hypertension
1.3
6.9
563
3930
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.2
6.9
1189
8991
S04
ICPC
Lump/swelling localized
1.2
6.9
1311
9998
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.2
6.9
1091
8191
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.1
6.9
2131
16854
S20
ICPC
Corn/callosity
1.4
6.9
289
1817
M54.2
ICD-10 Finland
Cervicalgia
1.2
6.9
929
6872
F94
ICPC
Blindness
5.9
6.9
18
27
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.1
6.9
2040
16097
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.2
6.9
957
7101
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
2.6
6.8
48
166
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
1.6
6.8
182
1039
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
2.1
6.8
76
330
R52.9
ICD-10 Finland
Pain, unspecified
1.2
6.8
1206
9145
AS4
HP
Physiological pacemaker insertion DDD (R)
1.5
6.8
235
1424
A02BA02
ATC
ranitidine; systemic
1.1
6.8
3695
30200
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
1.5
6.8
251
1543
N06
ICPC
Sensation disturbance other
1.7
6.8
127
661
C09DA01
ATC
losartan and diuretics; oral
1.1
6.8
1775
13877
37002
ICD-8 Finland
Refractive errors, Myopia
3.9
6.8
26
59
M79.1
ICD-10 Finland
Myalgia
1.1
6.8
1778
13905
3718X
ICD-9 Finland
Corneal opacity and other disorders of cornea, Other corneal disorders
5.5
6.8
19
31
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.1
6.8
2413
19260
G03DC05
ATC
[U] tibolone; oral
1.2
6.8
770
5593
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.2
6.8
1002
7478
S01
ICPC
Pain/tenderness of skin
1.3
6.8
588
4140
3608A
ICD-9 Finland
Disorders of the globe, Other disorders of globe[ANOPHTALMIA ARTEFACTA]
26.7
6.7
9
*
CGF10
NOMESCO Finland
Suture of laceration of cornea
3.3
6.7
32
87
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
4.2
6.7
24
51
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.1
6.7
1911
15033
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.3
6.7
475
3255
WX212
NOMESCO Finland
Femoral plexus blockade
1.4
6.7
274
1718
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
1.5
6.7
235
1429
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
1.4
6.7
261
1620
C03BA11
ATC
indapamide; oral
1.3
6.7
472
3233
H3601, E107
ICD-10 Finland
NA
8.3
6.7
14
15
V03AE01
ATC
polystyrene sulfonate; oral
1.6
6.7
179
1026
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
17.8
6.7
10
5
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
1.5
6.7
185
1067
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
6.7
1551
12026
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.2
6.7
1000
7472
F21
ICPC
NA
1.7
6.6
129
679
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.2
6.6
1002
7491
A10BH01
ATC
sitagliptin; oral
1.2
6.6
1589
12349
3665A
ICD-9 Finland
Cataract, After-cataract
5.3
6.6
19
32
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
2.3
6.6
56
214
H43.3
ICD-10 Finland
Other vitreous opacities
1.6
6.6
172
980
H20.2
ICD-10 Finland
Lens-induced iridocyclitis
6.1
6.6
17
25
Z49.2
ICD-10 Finland
Other dialysis
1.9
6.6
93
441
N05AH04
ATC
quetiapine; oral
1.1
6.6
2172
17249
L64.8
ICD-10 Finland
Other androgenic alopecia
4.3
6.6
23
48
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
1.3
6.6
430
2915
3604
FHL
Penetration of the cornea
4.7
6.6
21
40
WX780
NOMESCO Finland
Remote monitoring CPAP
1.3
6.6
453
3093
CJF40
NOMESCO Finland
Removal and implantation of artificial lens in anterior chamber
10.7
6.6
12
10
7433A
ICD-9 Finland
Congenital anomalies of eye, Congenital cataract and lens anomalies
10.7
6.6
12
10
F02
ICPC
Red eye
1.3
6.6
553
3879
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
2.4
6.5
51
189
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
1.4
6.5
253
1570
M81.0
ICD-10 Finland
Postmenopausal osteoporosis
1.3
6.5
371
2462
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
1.4
6.5
321
2081
3852
FHL
Reoperation for another reason
7.0
6.5
15
19
3671A
ICD-9 Finland
Disorders of refraction and accommodation, Myopia
5.1
6.5
19
33
R05FA02
ATC
opium derivatives and expectorants; systemic
1.1
6.5
7420
62650
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.1
6.5
2672
21514
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
1.5
6.5
226
1375
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
4.4
6.4
22
45
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.2
6.4
1120
8483
K05.1
ICD-10 Finland
Chronic gingivitis
1.2
6.4
860
6358
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.1
6.4
2669
21501
N02AX02
ATC
tramadol; systemic, rectal
1.1
6.4
8043
68137
M65.3
ICD-10 Finland
Trigger finger
1.3
6.4
565
3988
N40
ICD-10 Finland
Hyperplasia of prostate
1.1
6.4
3957
32540
CJE99
NOMESCO Finland
Other extracapsular cataract operation using phakoemulsification technique
3.1
6.4
32
91
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.2
6.4
635
4548
SPAT1251
SPAT
Organisation of medication
1.3
6.4
562
3967
CJB30
NOMESCO Finland
Excision of secondary cataract
3.7
6.4
26
63
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
6.2
6.3
16
23
J01FA06
ATC
roxithromycin; oral
1.1
6.3
7323
61838
B02.9
ICD-10 Finland
Zoster without complication
1.2
6.3
878
6511
E000007
ATC
NA
1.2
6.3
695
5032
CBN00
NOMESCO Finland
Eversion suture of eyelid
2.3
6.3
55
215
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.2
6.3
696
5040
C08CA05
ATC
nifedipine; systemic
1.2
6.3
1108
8400
P06
ICPC
Sleep disturbance
1.2
6.3
1248
9555
B01AF01
ATC
rivaroxaban; oral
1.1
6.3
2070
16439
CKD80
NOMESCO Finland
Retinectomy
14.8
6.3
10
6
J02AC02
ATC
itraconazole; systemic
1.1
6.3
2825
22857
-51
ICPC
I&d/flush/aspiration
1.5
6.3
176
1021
G03FB01
ATC
norgestrel and estrogen; systemic (progestogens and estrogens, sequential prep.)
1.4
6.3
289
1854
SPAT1172
SPAT
Guidance concerning hydration
1.3
6.3
358
2380
CJB99
NOMESCO Finland
Other operation on lens for secondary cataract
20.0
6.3
9
*
U07
ICPC
Urine symptom/complaint other
1.2
6.3
868
6441
S01GX09
ATC
olopatadine; ophthalmic
1.4
6.2
305
1977
S05.6
ICD-10 Finland
Penetrating wound of eyeball without foreign body
3.2
6.2
30
83
K07.60
ICD-10 Finland
Snapping jaw
1.3
6.2
499
3480
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
1.3
6.2
425
2899
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
1.3
6.2
499
3482
D86.0
ICD-10 Finland
Sarcoidosis of lung
1.6
6.2
158
896
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
2.9
6.2
34
103
H25.9
ICD-10 Finland
Senile cataract, unspecified
1.4
6.2
246
1535
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
4.2
6.2
22
47
D01AE16
ATC
amorolfine; topical
1.1
6.2
1949
15437
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
1.2
6.2
1155
8802
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
1.4
6.2
264
1668
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
2.3
6.2
54
212
37600
ICD-8 Finland
Detachment of retina, Primaria
3.4
6.2
28
74
H35.1
ICD-10 Finland
Retinopathy of prematurity
4.6
6.2
20
39
H360, E103
ICD-10 Finland
NA
4.6
6.2
20
39
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
1.7
6.2
119
625
H35.20
ICD-10 Finland
Proliferative vitreoretinopathy
5.9
6.2
16
24
J01MA06
ATC
norfloxacin; oral
1.1
6.2
2270
18157
6271A
ICD-9 Finland
Menopausal and postmenopausal disorders, Postmenopausal bleeding
1.6
6.2
159
905
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
1.5
6.2
215
1308
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.3
6.2
389
2627
R4160
SPAT
NA
3.3
6.2
29
79
H50.2
ICD-10 Finland
Vertical strabismus
1.8
6.2
95
465
WX723
NOMESCO Finland
CPAP therapy
1.3
6.2
403
2733
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.2
6.1
1384
10708
RJ120
NOMESCO Finland
NA
3.1
6.1
31
89
SPAT1307
SPAT
Psychosocial counselling and guidance
1.3
6.1
477
3315
Z02.7
ICD-10 Finland
Issue of medical certificate
1.2
6.1
829
6137
3660C
ICD-9 Finland
Cataract, Infantile, juvenile and presenile cataract[CATARACTA PRAESENILIS]
2.0
6.1
75
340
H16.1
ICD-10 Finland
Other superficial keratitis without conjunctivitis
2.2
6.1
58
235
L95
ICPC
Osteoporosis
1.3
6.1
474
3292
C09AA03
ATC
lisinopril; oral
1.2
6.1
787
5797
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.3
6.1
575
4092
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.3
6.1
575
4093
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
0.8
6.1
404
4602
R13
ICD-10 Finland
Dysphagia
1.2
6.1
996
7505
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.2
6.1
1433
11126
XF402
NOMESCO Finland
ECG with work load test
1.1
6.1
1905
15086
H20
ICD-10 Finland
Iridocyclitis
2.4
6.1
48
180
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.2
6.1
632
4553
QDH
NOMESCO Finland
Operations on toe nails
3.5
6.1
26
66
E000002
ATC
NA
1.1
6.1
1541
12030
K03.80
ICD-10 Finland
Irradiated enamel
1.3
6.0
488
3406
R06AX26
ATC
fexofenadine; oral
1.2
6.0
782
5765
B02
ICD-10 Finland
Zoster [herpes zoster]
1.3
6.0
513
3604
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.2
6.0
783
5772
R51
ICD-10 Finland
Headache
1.3
6.0
575
4100
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
8.9
6.0
12
12
TK820
NOMESCO Finland
Peritoneal dialysis
2.1
6.0
61
257
SPAT1313
SPAT
Guidance and counselling related to accident prevention
1.9
6.0
80
372
3626A
ICD-9 Finland
Other retinal disorders, Peripheral retinal degenerations
7.7
6.0
13
15
SFA00
NOMESCO Finland
Small filling
1.1
6.0
1816
14347
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
3.9
6.0
23
53
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.1
6.0
4068
33594

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023103) Potassium [Moles/volume] in Serum or Plasma
24494
200009
1.70
153.66
20.8
19.0
mmol/l
4.0
4.0
8.96
23804
194454
(3019550) Sodium [Moles/volume] in Serum or Plasma
24442
199608
1.69
151.28
20.6
18.8
mmol/l
139.5
139.7
7.65
23784
194382
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
22195
178112
1.49
137.66
7.0
6.2
mmol/mol
41.4
40.4
41.00
20044
162621
(3029937) Albumin [Presence] in Urine by Test strip
7751
52130
1.43
135.90
4.8
4.4
estimate
0.0
0.0
0.22
2653
16790
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10248
72724
1.38
129.50
4.7
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
21791
174835
1.46
128.83
5.3
4.9
mu/l
2.2
2.1
0.19
19413
157834
(3044889) 12 lead EKG panel
17795
138004
1.38
126.78
4.4
4.1
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
24473
201481
1.62
125.16
20.6
19.0
umol/l
81.3
80.0
5.40
24465
201389
(40761511) CBC panel - Blood by Automated count
23824
195124
1.55
122.00
17.4
15.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
24450
201512
1.60
120.88
11.8
11.1
u/l
24.6
25.4
5.63
23352
193277
(3035350) Ketones [Presence] in Urine by Test strip
12902
95661
1.35
119.76
4.4
3.9
estimate
0.0
0.0
1.28
2753
17307
(3035941) MCH [Entitic mass]
25060
207979
1.67
118.01
25.8
23.6
pg
30.4
30.4
2.14
24599
204313
(3026361) Erythrocytes [#/volume] in Blood
25062
208011
1.67
117.82
25.9
23.7
e12/l
4.4
4.4
35.87
24211
200889
(3024731) MCV [Entitic volume]
25061
208001
1.67
117.81
25.8
23.6
fl
91.6
91.5
7.12
24598
204334
(3007461) Platelets [#/volume] in Blood
25053
207924
1.67
117.70
25.9
23.7
e9/l
245.9
247.1
1.83
24325
201576
(3010813) Leukocytes [#/volume] in Blood
25064
208041
1.67
117.67
25.9
23.7
e9/l
6.8
6.8
0.09
24199
200975
(3000963) Hemoglobin [Mass/volume] in Blood
25064
208046
1.67
117.59
26.1
23.8
g/l
132.6
133.7
27.57
24601
204395
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
18477
145238
1.36
112.73
4.4
4.1
pmol/l
15.1
15.0
9.70
16338
130223
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
23296
190589
1.49
111.71
17.3
16.1
mg/l
24.5
25.5
3.73
18954
154273
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
6644
44755
1.40
110.85
1.8
1.7
pmol/l
43714838.9
29363326.3
0.95
5266
36226
(3009261) Glucose [Presence] in Urine by Test strip
12993
97182
1.33
109.72
4.5
4.0
estimate
0.0
0.0
0.26
2711
17204
(3021601) Nitrite [Presence] in Urine by Test strip
12845
96032
1.33
108.20
5.7
5.3
estimate
0.0
0.0
2.33
2781
17561
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
22824
186264
1.45
107.78
5.2
4.9
mmol/l
6.1
6.0
20.71
20193
167614
(3031040) Bacteria [#/volume] in Urine by Automated count
17078
133081
1.34
107.27
5.3
4.8
e6/l
1492.6
1535.9
0.03
290
1995
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
23257
190612
1.47
105.94
5.6
5.2
mmol/l
2.6
2.7
22.08
20838
173123
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
19415
154585
1.35
102.80
7.7
7.7
u/l
79.2
80.1
1.52
18116
144870
(3013707) Erythrocyte sedimentation rate by Westergren method
18365
145111
1.34
101.66
4.7
4.2
mm/h
14.0
13.7
1.38
16764
132947
(3037467) Urinalysis macro (dipstick) panel - Urine
17377
136690
1.32
95.96
5.1
4.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13897
106244
1.30
93.69
7.0
6.7
mmol/l
1.2
1.2
1.12
11363
89205
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
10884
80600
1.31
92.84
4.3
3.9
ng/l
67.2
69.2
0.05
8236
59162
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
22686
186059
1.41
92.69
5.0
4.7
mmol/l
4.5
4.6
13.59
20460
169774
(3002385) Erythrocyte distribution width [Ratio]
19167
153211
1.33
92.04
20.9
19.6
%
13.8
13.8
0.44
18685
149825
(3018418) pH of Serum or Plasma
8746
63106
1.32
89.08
4.5
4.1
ph
7.4
7.4
2.16
1897
11607
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
22464
184362
1.38
87.22
4.9
4.6
mmol/l
1.5
1.5
2.44
20044
167127
(40761536) Microorganisms panel - Urine sediment
2721
16093
1.54
87.09
4.6
4.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
9064
66056
1.31
84.70
3.6
3.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
10980
82092
1.29
84.35
2.4
2.2
nmol/l
79.4
1215.1
0.50
9619
72194
(3032080) INR in Blood by Coagulation assay
11610
87515
1.29
83.28
11.0
9.8
inr
1.3
1.3
0.10
3764
23702
(3012516) Albumin [Mass/volume] in Urine
8658
62938
1.30
81.65
3.5
3.2
mg/l
509.3
412.8
0.94
5373
39266
(3024561) Albumin [Mass/volume] in Serum or Plasma
12035
91286
1.28
81.50
4.8
4.7
g/l
34.9
34.9
0.21
11015
84078
(3019309) Folate [Moles/volume] in Red Blood Cells
6182
43008
1.34
79.28
1.9
1.8
nmol/l
1241.3
1155.3
9.88
4623
31938
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
12645
96708
1.27
79.21
6.2
6.0
mmol/l
1.2
1.2
3.32
11344
86817
(3013826) Glucose [Moles/volume] in Serum or Plasma
15271
119619
1.27
78.03
5.1
4.8
mmol/l
6.9
6.8
9.86
14349
112404
(3020682) Albumin/Creatinine [Ratio] in Urine
9047
66458
1.29
77.77
4.4
3.9
mg/mmol
10.9
9.0
2.32
5622
41207
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
3372
21355
1.44
76.13
3.7
3.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6938
49435
1.31
74.27
4.0
3.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
8787
64610
1.29
73.98
3.5
3.2
mmol/l
6.9
7.2
11.11
7261
53325
(3019150) Specific gravity of Urine by Refractometry
6033
42277
1.32
72.47
5.0
4.4
kg/l
1.0
1.0
0.36
936
6589
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
11517
88037
1.26
68.59
2.1
2.1
pmol/l
95.5
94.9
0.64
5657
45158
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
21649
178279
1.31
68.34
4.4
4.2
mmol/l
1.3
1.3
2.05
19142
160168
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
7288
52840
1.29
66.94
2.4
2.3
mg/l
3.0
3.1
0.43
6196
44687
(40760892) CBC W Ordered Manual Differential panel - Blood
5644
39639
1.31
65.67
4.7
4.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2746
17419
1.43
60.47
4.1
3.9
mmol/l
1.2
1.2
0.22
2354
15118
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
7000
51121
1.27
59.11
1.7
1.6
mmol/l
1.3
1.3
1.67
5497
42441
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
8592
64302
1.25
58.79
2.2
2.2
u/l
190.6
211.5
1.53
7934
59911
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
8565
64088
1.25
58.67
2.8
2.6
u/l
60.2
59.2
0.48
7800
58765
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
8818
66250
1.25
58.11
3.1
3.1
ng/l
1665.5
1614.5
0.41
7543
57137
(3001122) Ferritin [Mass/volume] in Serum or Plasma
10267
78823
1.23
54.26
3.0
2.9
ug/l
139.9
147.6
2.07
9215
71792
(3000850) Epithelial cells [#/volume] in Urine
6110
44401
1.27
52.60
2.9
2.7
e6/l
5.4
5.3
0.28
5353
38741
(3007853) Bacteria identified in Skin by Aerobe culture
3485
23583
1.34
51.09
1.9
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
6854
50634
1.25
50.91
1.6
1.6
nmol/l
20.9
20.5
1.28
5767
42771
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
13460
106942
1.21
47.98
5.7
6.2
umol/l
11.6
11.7
0.39
12617
101267
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
21600
179926
1.25
47.35
16.4
15.3
ml/min/173m2
74.1
76.0
33.41
17778
149031
(3021589) Normoblasts [#/volume] in Blood
10902
85316
1.20
44.34
11.3
10.1
e9/l
0.0
0.0
1.78
9146
69495
(3015377) Calcium [Moles/volume] in Serum or Plasma
9245
71241
1.21
44.27
3.2
3.4
mmol/l
2.4
2.4
1.16
7934
60956
(3008152) Bicarbonate [Moles/volume] in Arterial blood
2129
13643
1.40
43.55
6.4
6.9
mmol/l
24.5
24.7
1.64
1984
12728
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
5189
37825
1.25
42.00
1.3
1.2
u/ml
1.7
1.7
0.10
1428
9417
(3013650) Neutrophils [#/volume] in Blood by Automated count
14075
113309
1.19
39.89
8.7
9.1
e9/l
4.2
4.2
1.20
12384
98103
(3006315) Basophils [#/volume] in Blood
12274
97849
1.18
38.39
6.0
5.8
e9/l
0.0
0.0
0.56
10666
83391
(3013115) Eosinophils [#/volume] in Blood
12617
100846
1.18
38.18
6.2
6.0
e9/l
0.2
0.2
0.89
11096
87197
(3026782) Osmolality of Urine
5618
41679
1.23
38.14
3.0
2.9
mosm/kgh2o
523.7
544.3
11.16
4775
35352
(3001604) Monocytes [#/volume] in Blood
12199
97309
1.18
37.56
6.0
5.8
e9/l
0.6
0.6
0.23
10599
82881
(3019198) Lymphocytes [#/volume] in Blood
12470
99656
1.18
37.54
6.1
5.8
e9/l
1.9
1.9
0.74
11017
86406
(42870588) Differential panel, method unspecified - Blood
8815
68456
1.19
36.90
5.9
5.8
—
—
—
0
0
(40761535) Cells panel - Urine sediment
2589
17694
1.31
34.51
3.9
3.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
2250
15105
1.33
33.98
4.0
4.1
%
0.5
0.3
0.52
527
3981
(3036481) Cortisol [Moles/volume] in Serum or Plasma
2495
17011
1.32
33.80
2.1
2.3
nmol/l
382.3
376.9
0.46
2253
15560
(3009542) Hematocrit [Volume Fraction] of Blood
19974
166732
1.19
33.28
18.7
17.5
%
38.5
39.0
7.98
11774
110321
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
2435
16587
1.32
33.17
4.1
3.7
ng/l
99.0
92.5
2.23
2026
14047
(3017181) Myelocytes/100 leukocytes in Blood
2489
17040
1.31
32.67
4.0
4.0
%
1.0
0.9
0.29
672
5071
(3019060) Gas panel - Arterial blood
2172
14659
1.33
31.53
4.4
4.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
3673
26569
1.25
30.74
8.5
7.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
1087
6560
1.47
30.65
5.1
6.0
mmol/l
1.3
1.3
1.62
964
5800
(3021440) Promyelocytes/100 leukocytes in Blood
2359
16176
1.31
30.51
4.0
4.0
%
0.1
0.1
0.41
616
4705
(3018095) Leukocytes [#/volume] in Urine
9253
73043
1.17
30.08
4.1
3.9
e6/l
103.7
116.8
0.76
6970
52289
(36304419) Bacteria [Presence] in Urine
7253
56218
1.18
29.40
3.4
3.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
6146
46975
1.19
29.32
4.4
3.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
7498
58473
1.17
27.88
3.4
3.3
e6/l
0.4
0.5
1.64
5899
44162
(40767503) Oxygen content in Capillary blood by calculation
793
4580
1.54
27.65
2.5
2.6
%
16.2
16.0
0.84
428
2390
(3022948) Iron [Moles/volume] in Serum or Plasma
4501
33615
1.21
27.35
2.8
2.5
umol/l
12.1
12.4
3.12
4103
30884
(3002179) Metamyelocytes/100 leukocytes in Blood
2237
15451
1.29
27.28
3.8
3.9
%
0.6
0.7
0.50
480
3654
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1248
7904
1.40
27.08
2.1
1.8
u/l
40.0
38.8
1.20
1108
6817
(3039000) Anion gap in Blood
804
4718
1.51
26.05
5.7
6.8
mmol/l
11.3
11.2
0.31
730
4236
(3018572) Chloride [Moles/volume] in Blood
804
4719
1.51
26.02
5.7
6.8
mmol/l
104.8
105.1
0.99
730
4237
(3010421) pH of Blood
924
5582
1.47
25.94
4.5
4.0
ph
7.4
7.4
2.06
769
4758
(3002582) Erythrocytes [#/volume] in Urine
8079
63647
1.16
25.93
3.6
3.4
e6/l
111.7
100.4
0.19
6448
48866
(3023368) Bacteria identified in Blood by Culture
7576
59429
1.16
25.66
4.4
4.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
4162
31219
1.20
23.79
2.8
2.5
g/l
2.3
2.3
0.53
3784
28666
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
2714
19522
1.24
23.47
3.2
3.0
ng/l
214.1
234.4
1.52
2498
17890
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
84
219
3.37
22.64
5.4
4.9
—
—
—
0
0
(3013512) EKG study
7838
62156
1.15
22.14
4.4
4.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
4650
35439
1.18
22.01
1.9
1.9
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
3909
29351
1.20
21.92
2.9
2.6
%
21.6
21.9
0.73
3167
24841
(3022096) Basophils/100 leukocytes in Blood
10975
89098
1.14
21.67
6.3
6.1
%
0.7
0.7
0.27
10176
82424
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
347
1731
1.77
21.67
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
3704
27705
1.20
21.64
6.5
5.5
mmol/l
1.0
1.0
1.22
3417
25493
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
3287
24357
1.21
21.18
1.8
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
1339
8917
1.33
21.18
4.8
5.0
%
0.9
0.9
1.57
1249
8369
(3002030) Lymphocytes/100 leukocytes in Blood
11510
93933
1.13
20.49
6.5
6.2
%
26.5
26.9
3.80
10646
86622
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
3276
24340
1.21
20.49
1.8
1.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
4291
32672
1.18
20.37
2.0
2.0
s
29.9
29.9
0.22
4147
31686
(3006504) Eosinophils/100 leukocytes in Blood
11241
91627
1.13
20.36
6.3
6.0
%
2.9
2.8
1.57
10410
84721
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
835
5184
1.43
20.33
2.5
2.3
ug/min
146.7
111.3
0.93
461
2970
(3019069) Monocytes/100 leukocytes in Blood
11293
92112
1.13
20.16
6.6
6.3
%
8.9
8.8
2.56
10496
85482
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2800
20531
1.22
20.02
6.5
7.6
g/l
120.0
120.3
0.34
2686
19803
(1616796) Gas panel - Central venous blood
780
4804
1.44
19.85
3.8
3.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5210
40388
1.16
19.67
3.0
3.1
mmol/l
2.5
2.5
0.45
4547
35045
(3028271) Lactate [Moles/volume] in Capillary blood
582
3399
1.51
19.39
2.0
1.9
mmol/l
1.8
1.7
0.65
573
3319
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1344
9069
1.32
19.38
4.8
5.0
%
1.6
1.6
0.66
1257
8518
(3018010) Neutrophils/100 leukocytes in Blood
11313
92472
1.13
19.13
6.2
5.9
%
58.5
58.0
4.42
10482
85673
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
2213
15916
1.24
19.01
1.6
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
785
4886
1.42
18.87
4.6
4.0
kpa
5.0
5.0
0.56
770
4753
(3027315) Oxygen [Partial pressure] in Blood
788
4914
1.42
18.74
4.6
4.1
kpa
8.5
8.5
0.64
773
4780
(3012501) Base excess in Blood by calculation
784
4885
1.42
18.73
4.6
4.0
mmol/l
2.6
2.7
0.42
557
3368
(3020891) Body temperature
1284
8656
1.32
18.65
4.8
4.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
7288
58064
1.14
18.46
3.4
3.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
2667
19639
1.21
18.19
2.5
2.4
ug/l
6.1
7.0
1.24
2258
16816
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
786
4936
1.41
17.98
3.3
2.9
mg/l
1.7
1.7
1.07
709
4445
(3016502) Oxygen saturation in Arterial blood
3018
22530
1.20
17.78
6.1
7.1
%
95.7
95.4
1.43
2889
21677
(3008898) HLA-B27 [Presence]
721
4470
1.43
17.74
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
798
5047
1.40
17.53
2.1
1.9
mg/l
10.7
11.6
2.48
737
4640
(3007164) IgA [Mass/volume] in Serum or Plasma
4326
33323
1.17
17.51
1.5
1.5
g/l
2.5
2.6
0.32
2512
19036
(3027945) Reticulocytes/100 erythrocytes in Blood
3363
25399
1.18
17.34
2.5
2.4
%
1.8
1.8
0.01
2923
22221
(3023520) Reticulocytes [#/volume] in Blood
2588
19114
1.21
17.07
2.6
2.5
e9/l
69.2
68.8
0.21
2044
14494
(3012095) Magnesium [Moles/volume] in Serum or Plasma
4407
34125
1.16
16.55
3.0
3.2
mmol/l
0.8
0.8
1.46
4041
31537
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
5370
42307
1.14
15.68
1.7
1.7
mg/l
1.4
1.4
0.13
4135
32854
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
4072
31481
1.16
15.53
1.3
1.3
iu/ml
35.1
39.5
1.02
1307
9803
(3022806) Fractional oxyhemoglobin in Capillary blood
468
2740
1.51
15.51
2.0
1.8
%
89.1
89.3
0.29
463
2700
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
599
3685
1.44
15.43
3.8
3.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
2209
16250
1.21
15.14
2.9
2.8
ml/min/173m2
57.3
61.9
6.71
900
6768
(3006184) Hemoglobin [Mass/volume] in Capillary blood
777
5023
1.37
15.01
2.1
2.2
g/l
127.4
127.7
0.10
620
3560
(3026493) Urate [Moles/volume] in Serum or Plasma
6705
53702
1.13
14.99
2.8
2.7
umol/l
5185.7
5375.9
0.13
5671
45601
(3020630) Protein [Mass/volume] in Serum or Plasma
2513
18748
1.19
14.80
2.5
2.6
g/l
66.3
66.2
0.30
2244
16831
(3003396) Base excess in Arterial blood by calculation
3305
25241
1.17
14.73
6.0
6.8
mmol/l
1.1
1.1
0.20
2498
19953
(3037522) Nuclear Ab [Titer] in Serum
3227
24613
1.17
14.62
1.3
1.3
titre
577.5
541.2
0.44
696
5427
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7592
61331
1.12
14.56
3.3
3.2
u/l
35.1
35.0
0.02
7077
57793
(3020961) Endomysium IgA Ab [Titer] in Serum
1088
7468
1.29
13.87
1.2
1.1
titre
187.8
233.8
0.26
20
175
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
2477
18559
1.19
13.87
1.5
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
623
3936
1.40
13.87
1.4
1.3
mmol/l
59.6
62.4
1.13
506
3131
(3030905) Polymorphonuclear cells [#/volume] in Blood
594
3728
1.41
13.74
3.5
3.2
e9/l
4.3
4.2
0.38
594
3717
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
182
862
1.86
13.68
1.2
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
2112
15637
1.20
13.49
2.4
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
931
10518
0.77
13.36
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
1435
10235
1.24
13.27
1.3
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
3759
29212
1.15
13.17
2.2
2.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
143
645
1.95
12.50
1.9
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1788
13126
1.21
12.50
3.6
3.3
g/l
125.4
127.6
3.82
1741
12801
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
14117
118311
1.10
12.49
3.2
3.1
u/l
51.7
52.8
0.63
12813
108361
(3043409) Potassium [Moles/volume] in Arterial blood
966
6625
1.29
12.43
4.1
4.3
mmol/l
3.9
3.9
0.23
898
6213
(3000494) Fungus identified in Specimen by Culture
2976
22851
1.16
12.26
1.5
1.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
3266
25259
1.15
12.19
6.1
6.8
kpa
12.1
12.1
0.02
3113
24005
(3015235) Bicarbonate [Moles/volume] in Capillary blood
829
5586
1.31
12.18
3.0
3.1
mmol/l
24.6
24.9
0.99
754
4880
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
3268
25278
1.15
12.17
6.1
6.8
kpa
5.0
5.1
3.50
3105
24041
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
298
1670
1.57
12.17
1.5
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5247
41864
1.12
12.11
4.1
4.0
ng/l
413.1
453.9
0.26
4361
34398
(3018405) Lactate [Moles/volume] in Arterial blood
1102
7709
1.27
12.09
4.0
4.0
mmol/l
1.3
1.4
2.46
1083
7568
(3048689) Calprotectin [Mass/mass] in Stool
2711
20707
1.17
11.95
2.1
2.1
ug/g
135.1
146.1
0.82
2042
15991
(3027273) Bicarbonate [Moles/volume] in Venous blood
1480
10718
1.22
11.88
3.8
3.4
mmol/l
25.1
25.3
0.76
1428
10416
(3000570) Elastase.pancreatic [Mass/mass] in Stool
898
6143
1.29
11.80
1.5
1.4
ug/g
259.9
266.7
0.47
553
3641
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1619
11862
1.21
11.56
2.5
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
289
1632
1.56
11.45
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
257
1414
1.60
11.38
1.1
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
195
1002
1.71
11.25
2.2
2.1
ml
1797.7
1881.5
0.65
174
858
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
262
1460
1.58
11.01
2.3
2.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
113
493
2.02
10.92
5.4
5.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
815
5566
1.29
10.88
3.4
3.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
335
1982
1.49
10.72
1.5
1.3
mosm/kgh2o
276.1
277.3
0.44
270
1485
(3022145) Colonoscopy Study observation
2889
22347
1.15
10.70
1.3
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11180
93127
1.09
10.61
4.3
4.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
307
1792
1.51
10.50
1.1
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
720
4865
1.31
10.43
2.8
3.0
kpa
8.1
7.9
1.97
676
4503
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
567
3706
1.35
10.35
6.3
5.0
iu/ml
768.5
1465.8
0.63
96
551
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1692
12588
1.19
10.25
1.5
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
1876
14085
1.18
10.22
2.7
2.8
g/l
10.6
10.6
0.04
1682
12851
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1046
7436
1.24
10.04
3.2
3.3
mg/l
44.8
45.8
0.06
806
6057
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
3233
25314
1.14
9.98
3.8
4.1
u/l
243.8
246.8
0.58
3019
23802
(3034860) Kappa light chains.free [Mass/volume] in Serum
1047
7453
1.24
9.93
3.2
3.3
mg/l
55.6
75.7
1.09
809
6072
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1018
7226
1.25
9.91
3.2
3.2
ratio
8.8
4.6
0.31
84
531
(3021901) Oxygen saturation in Capillary blood
619
4127
1.32
9.90
2.7
2.9
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1384
10165
1.21
9.66
3.0
2.8
%
1.2
1.2
0.03
1374
10113
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1007
7160
1.24
9.66
1.3
1.2
u/ml
1.0
0.9
0.12
94
677
(40768797) Stomach Pathology biopsy report
3561
28133
1.13
9.50
1.2
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
143
709
1.77
9.44
1.1
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1568
11675
1.19
9.43
7.7
9.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
209
1158
1.59
9.10
1.4
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
2488
19261
1.15
9.08
8.5
6.7
mmol/l
11.0
10.6
2.09
2349
18165
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1509
11253
1.19
8.92
3.1
2.8
e6/l
0.3
0.3
0.17
1479
10989
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
209
1165
1.58
8.88
1.4
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
365
2287
1.41
8.72
1.5
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
3729
29694
1.12
8.65
1.3
1.3
u/ml
12.5
14.5
0.85
1320
10716
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
878
6241
1.24
8.49
1.8
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
772
5408
1.26
8.49
1.6
1.6
iu/ml
17.9
8.4
0.45
179
1257
(3024354) Oxygen [Partial pressure] in Venous blood
2153
16579
1.15
8.48
3.5
3.2
kpa
4.6
4.5
0.87
2075
16014
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1343
9964
1.19
8.43
3.0
2.8
%
0.7
0.7
0.21
1282
9563
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
168
905
1.63
8.26
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
494
3287
1.32
8.10
1.7
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2585
20214
1.14
8.10
4.1
3.8
kpa
5.8
5.8
0.26
2496
19617
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
92
418
1.93
8.06
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
486
3232
1.33
8.01
1.3
1.5
—
—
—
0
0
(3024471) HLA-A [Type]
107
513
1.83
7.96
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
231
1351
1.50
7.96
1.4
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
474
3144
1.33
7.96
1.4
1.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
1330
9916
1.19
7.92
4.4
4.1
%
47.5
47.4
0.06
1314
9804
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
992
7198
1.22
7.91
1.1
1.1
u/ml
0.9
7.2
1.00
14
108
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
425
2780
1.35
7.85
1.3
1.4
—
—
—
0
0
(4062490)
296
1825
1.43
7.80
1.3
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
565
3855
1.29
7.74
1.5
1.4
e6/l
1332.8
1912.2
0.34
473
3140
(3024139) IgG subclass 3 [Mass/volume] in Serum
296
1830
1.42
7.69
1.3
1.4
g/l
0.4
0.4
0.21
197
1285
(3027135) IgG subclass 1 [Mass/volume] in Serum
296
1831
1.42
7.67
1.3
1.4
g/l
6.5
6.9
0.94
197
1281
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
564
3852
1.29
7.67
1.4
1.4
e6/l
23.0
29.9
0.32
446
2975
(3028192) IgG subclass 2 [Mass/volume] in Serum
296
1832
1.42
7.65
1.3
1.4
g/l
2.8
2.9
0.93
197
1285
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
670
7344
0.80
7.63
1.5
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
1240
9223
1.19
7.60
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
532
3611
1.30
7.59
1.4
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
151
815
1.63
7.42
1.2
1.3
%
58.2
58.5
0.01
14
93
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
430
2843
1.33
7.42
3.0
2.4
u/ml
625.0
4831.6
0.72
30
170
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
485
3265
1.31
7.37
1.6
1.4
u/ml
8.2
21.3
—
5
54
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
16
28
5.02
7.35
1.5
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
2568
20195
1.13
7.35
4.3
3.8
mmol/l
1.9
1.9
0.52
2061
16494
(3028026) IgM [Mass/volume] in Serum or Plasma
1464
11076
1.17
7.32
1.9
1.9
g/l
1.4
1.3
0.17
1299
9979
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
630
4391
1.27
7.30
1.1
1.1
u/ml
4.8
9.1
0.92
39
395
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1486
11261
1.17
7.28
3.1
3.3
pmol/l
4.4
4.4
0.01
1296
9891
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
1094
11361
0.84
7.26
1.8
1.8
—
—
—
0
0
(3012544) pH of Venous blood
2660
20980
1.12
7.25
4.1
3.8
ph
7.4
7.4
0.11
20
101
(3026389) Candida sp identified in Specimen by Organism specific culture
427
2835
1.33
7.17
1.4
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
102
502
1.79
7.03
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
899
6543
1.21
7.00
1.3
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
107
535
1.76
7.00
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
119
614
1.70
6.97
1.1
1.1
miu/ml
1681.2
1528.9
0.82
119
614
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
437
2926
1.32
6.93
1.7
1.4
u/ml
115.5
118.7
0.32
116
650
(3042631) Mycobacterium sp identified in Specimen
466
3150
1.30
6.90
2.7
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
696
4947
1.24
6.83
1.5
1.6
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
16
30
4.68
6.82
1.6
1.7
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
284
1786
1.40
6.76
1.2
1.2
nmol/l
340.7
336.7
0.12
229
1426
(3005322) IgE [Units/volume] in Serum or Plasma
1355
10258
1.17
6.74
1.3
1.3
u/ml
187.0
234.9
1.54
1245
9410
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
102
509
1.76
6.73
1.1
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
124
654
1.67
6.71
2.6
2.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
124
654
1.67
6.71
2.6
2.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
381
2515
1.33
6.69
10.5
10.2
mmol/l
7.6
7.5
0.20
325
2052
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
666
4724
1.24
6.67
1.5
1.6
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
44
162
2.39
6.61
1.3
1.3
pmol/l
13.5
17.3
0.40
38
141
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
417
2812
1.31
6.33
1.5
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
1215
9171
1.17
6.30
1.9
1.9
ug/l
2.2
2.2
0.00
1049
8017
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
687
4936
1.23
6.14
1.5
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
301
1951
1.36
6.02
3.1
3.0
mg/l
69.1
46.6
0.53
217
1402
(36660697) Celiac disease serology panel - Serum
1783
13904
1.13
5.87
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
767
5606
1.21
5.79
1.8
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
11877
100608
1.06
5.79
2.5
2.5
—
—
—
0
0
(3000012) Reticulocyte production index
203
1241
1.44
5.74
1.7
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
9569
80563
1.07
5.62
2.2
2.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
256
1637
1.38
5.61
1.3
1.3
nmol/l
1.4
1.4
0.08
230
1483
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
51
217
2.06
5.49
1.2
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
85
430
1.74
5.44
2.1
1.9
mg/l
10.5
8.9
1.61
59
354
(3004451) EKG impression Narrative
184
1117
1.45
5.43
1.3
1.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
17979
154405
1.06
5.40
23.5
21.2
g/l
331.4
331.5
0.38
17844
153003
(3020876) Protein [Mass/time] in 24 hour Urine
287
1881
1.34
5.39
2.0
1.9
g/24h
0.8
1.0
—
7
85
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
164
976
1.48
5.36
1.2
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
29
97
2.63
5.36
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
615
4436
1.22
5.35
1.3
1.3
mg/l
556.0
553.7
0.03
587
4197
(4027681)
142
822
1.52
5.31
1.3
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
546
3897
1.23
5.26
1.3
1.3
mmol/l
3.9
3.8
0.90
514
3649
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
185
1133
1.44
5.23
2.1
2.0
nmol/l
16.3
16.5
0.09
174
1057
(3019977) pH of Arterial blood
201
1252
1.41
5.18
2.7
2.5
ph
7.4
7.4
0.16
74
451
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
95
503
1.66
5.18
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
312
3560
0.77
5.09
3.4
3.5
u/ml
55.1
39.8
0.47
299
3443
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
151
894
1.49
5.09
1.2
1.1
ratio
1.1
1.1
0.93
49
308
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
135
781
1.52
5.08
1.8
2.0
ug/l
54.8
59.1
0.33
128
765
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
420
2923
1.27
5.08
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
357
2436
1.29
5.06
1.2
1.3
nmol/l
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1172
8995
1.15
4.95
1.5
1.5
u/ml
12.5
16.8
0.58
28
219
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
507
3617
1.23
4.94
1.5
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
987
7483
1.16
4.92
1.5
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
143
844
1.49
4.91
1.4
1.4
%
62.9
64.3
0.18
107
697
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
74
372
1.75
4.89
3.1
2.5
au/ml
92.2
186.2
0.70
11
47
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
571
4131
1.22
4.86
1.2
1.2
titre
64.0
143.7
—
10
86
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1020
7764
1.16
4.83
2.8
2.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1352
10496
1.14
4.83
1.6
1.6
g/l
1.6
1.6
0.40
1129
8908
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
98
534
1.61
4.80
1.1
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
77
397
1.70
4.67
3.4
3.2
mg/l
6.1
7.6
1.64
56
324
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
281
1880
1.32
4.65
1.1
1.1
iu/ml
2.4
1.9
—
9
64
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
66
326
1.78
4.65
1.1
1.2
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
33
128
2.26
4.52
1.6
1.8
mg/l
1.6
1.6
0.01
28
104
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
68
342
1.75
4.52
1.8
1.6
au/ml
128.7
89.7
—
7
48
(3000919) Neutrophils/100 leukocytes in Pleural fluid
113
649
1.53
4.45
1.4
1.4
%
22.7
19.9
0.47
100
584
(3004775) Volume in Urine collected for unspecified duration
268
1795
1.31
4.42
2.5
2.2
ml
705.8
663.6
0.61
178
1179
(3011412) CD3 cells [#/volume] in Blood
256
1705
1.32
4.40
2.3
2.3
e9/l
1.0
1.1
0.56
161
1030
(3028433) Virus identified in Specimen by Culture
113
651
1.53
4.40
1.2
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
123
722
1.50
4.39
1.4
1.4
%
2.4
2.5
0.07
94
610
(40758558) Short blood count panel - Blood
6055
50579
1.07
4.36
6.6
7.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
589
6132
0.84
4.19
1.7
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1601
12672
1.12
4.18
6.0
6.6
mmol/l
24.7
24.8
0.80
1584
12541
(3016750) Collection duration of Urine
196
1268
1.36
4.12
2.3
2.1
min
490.4
500.0
0.79
140
918
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7962
67157
1.06
4.10
5.5
5.3
ug/l
3.9
3.8
0.05
6976
59655
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
94
530
1.56
4.06
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
3048
24908
1.08
4.06
1.4
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
3742
30829
1.08
4.03
29.1
27.5
inr
1.5
1.4
0.59
449
4253
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
110
646
1.50
3.96
1.1
1.1
%
97.2
95.8
0.19
85
499
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
178
1143
1.37
3.94
3.6
3.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
1608
12785
1.11
3.89
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
201
1319
1.34
3.88
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
396
2834
1.23
3.85
1.3
1.2
u/ml
288.1
289.7
0.04
270
1754
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
586
4354
1.19
3.84
1.7
1.7
iu/l
4.2
8.8
0.87
168
1473
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
345
2436
1.25
3.80
1.3
1.3
pmol/l
297.7
285.1
0.19
280
1857
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
5411
49836
0.94
3.79
2.5
2.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
83
1117
0.65
3.75
1.3
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
493
3618
1.20
3.73
1.2
1.2
u/ml
44.4
45.6
0.05
53
367
(3024980) IgG subclass 4 [Mass/volume] in Serum
406
2924
1.22
3.73
1.5
1.6
g/l
0.6
0.8
3.83
283
2216
(3045716) Anion gap in Serum or Plasma
153
969
1.39
3.71
3.3
2.3
mmol/l
9.3
9.0
0.44
105
728
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
389
2791
1.23
3.71
1.3
1.3
nmol/l
0.6
2.0
1.49
372
2673
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
636
4780
1.17
3.66
1.9
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
2102
16988
1.09
3.65
1.7
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
3319
27327
1.08
3.64
6.3
6.7
mmol/l
104.1
104.3
2.35
3211
26722
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
627
4711
1.17
3.62
1.3
1.3
u/ml
6.5
6.5
0.01
100
780
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
6351
53398
1.06
3.60
4.9
4.6
%
22.1
22.2
0.12
3321
27666
(3010375) cycloSPORINE [Mass/volume] in Blood
128
791
1.42
3.59
25.0
27.8
ug/l
108.9
111.0
0.12
109
666
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
171
1110
1.35
3.58
2.4
2.4
e9/l
0.2
0.2
0.33
157
973
(3003327) Ova and parasites identified in Stool by Light microscopy
748
5703
1.16
3.58
1.6
1.7
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
217
1459
1.31
3.57
1.1
1.2
mmol/l
31.5
34.9
1.57
189
1221
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
1344
10636
1.11
3.57
1.2
1.2
iu/ml
143.8
137.2
0.21
478
3880
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
899
6947
1.14
3.55
1.6
1.6
titre
178.9
246.1
0.76
40
316
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
388
2798
1.22
3.54
1.3
1.3
nmol/l
0.2
0.3
0.93
24
216
(3009343) pH of Capillary blood
1704
13663
1.10
3.52
3.5
3.7
ph
7.4
7.4
0.42
311
1710
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
124
765
1.42
3.52
1.6
1.6
nmol/l
2.9
4.7
0.99
102
642
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
178
1167
1.34
3.50
2.3
2.3
e6/l
504.2
536.4
0.30
157
980
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
417
3033
1.21
3.49
1.3
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
618
4653
1.17
3.49
1.3
1.3
u/ml
12.0
5.1
0.66
67
499
(3033923) Metanephrine [Moles/time] in 24 hour Urine
80
453
1.55
3.46
1.0
1.1
umol/24h
0.6
0.7
0.56
35
212
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
35
156
1.97
3.45
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
741
5664
1.15
3.44
1.6
1.5
g/l
1.2
1.2
0.33
710
5352
(3017704) Immunofixation for Urine
188
1248
1.32
3.41
1.4
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
672
5104
1.16
3.40
1.3
1.2
u/ml
32.8
40.1
0.27
37
298
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
129
807
1.40
3.40
1.1
1.1
u/l
1.1
1.1
0.18
64
401
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
22
417
0.46
3.38
1.0
1.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
167
1091
1.35
3.38
1.1
1.1
mg/l
309.5
290.4
0.34
142
952
(3011985) Renin [Units/volume] in Plasma
363
2617
1.22
3.34
1.4
1.4
mu/l
68.5
58.0
0.46
324
2305
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
719
5499
1.15
3.32
1.6
1.6
g/l
0.2
0.2
0.46
689
5172
(3006969) Lambda light chains [Mass/volume] in Urine
16
51
2.75
3.31
1.1
1.1
g/l
0.0
0.0
—
7
23
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1719
13840
1.10
3.27
3.6
3.7
kpa
5.2
5.2
0.05
1574
12712
(3048929) Epstein Barr virus Ab [Presence] in Serum
544
4080
1.17
3.26
1.3
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
263
1837
1.26
3.25
2.1
2.1
u/field
2.6
2.4
0.14
95
721
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
173
1146
1.33
3.21
1.2
1.1
mg/l
43.7
43.2
0.04
140
958
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
79
1036
0.67
3.21
1.3
1.4
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
135
861
1.38
3.20
1.5
1.5
ug/l
9.0
9.2
0.04
122
789
(4010399)
1843
14906
1.09
3.18
1.5
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
185
1239
1.31
3.18
2.3
2.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
79
1034
0.67
3.18
1.3
1.4
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
49
251
1.71
3.17
1.5
1.9
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
688
5267
1.15
3.16
1.6
1.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
58
312
1.63
3.13
10.2
11.3
mmol/l
5.8
5.3
0.32
58
312
(3006245) CD3-CD19+ cells/100 cells in Blood
96
579
1.46
3.12
2.4
1.9
%
10.8
10.9
0.02
89
517
(3049717) Cytology report of Urine Cyto stain
1143
9042
1.11
3.11
2.7
2.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
80
1039
0.67
3.10
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
80
1038
0.68
3.09
1.3
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
109
675
1.42
3.08
1.3
1.8
u/ml
31507.8
33513.1
0.03
18
105
(3020650) Glucose [Presence] in Urine
71
403
1.55
3.08
1.6
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
91
546
1.46
3.04
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
378
2766
1.20
3.03
2.3
2.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
42
209
1.76
3.01
1.1
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
4377
36593
1.06
3.01
2.9
2.9
e6/l
1.8
1.2
0.50
2693
21045
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
465
3469
1.18
3.00
1.3
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
103
1268
0.71
2.99
1.5
1.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
194
1321
1.29
2.98
2.1
1.9
%
69.6
71.6
0.84
185
1250
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
104
643
1.42
2.98
1.3
1.5
pmol/l
15.7
16.0
0.19
85
535
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
190
1292
1.29
2.95
2.1
1.9
%
16.1
15.2
0.28
88
523
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1223
11813
0.90
2.95
7.8
8.4
mmol/l
24.1
24.4
2.66
1111
10937
(3008116) Ketones [Moles/volume] in Urine by Test strip
68
387
1.54
2.93
1.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
156
1034
1.33
2.92
2.4
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
67
888
0.66
2.91
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
528
3992
1.16
2.90
1.5
1.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
13
40
2.85
2.88
3.5
3.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
523
3955
1.16
2.87
1.2
1.2
u/ml
7.6
12.0
—
10
51
(3022493) Free Hemoglobin [Mass/volume] in Plasma
130
842
1.36
2.85
5.5
3.5
mg/l
2181.5
608.1
0.33
87
595
(3010838) Calcium [Moles/time] in 24 hour Urine
157
1050
1.31
2.78
1.5
1.6
mmol/24h
4.0
5.7
—
5
71
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1631
13207
1.09
2.78
3.5
3.6
mmol/l
1.9
1.9
0.27
1157
9873
(3016650) Hepatitis A virus Ab [Presence] in Serum
368
2712
1.19
2.77
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
96
1178
0.71
2.76
1.5
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
350
2570
1.20
2.74
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
2288
18802
1.07
2.69
1.7
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
173
1179
1.29
2.68
13.9
10.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
89
547
1.43
2.67
1.2
1.3
%
32.6
23.2
0.42
11
92
(3047352) Trisomy 18 risk [Likelihood] in Fetus
66
859
0.67
2.65
1.3
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
482
3650
1.16
2.63
1.6
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
209
1462
1.26
2.63
1.3
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
2017
18958
0.93
2.62
2.7
2.4
u/l
40.9
46.1
0.47
1681
16119
(3017732) Neutrophils [#/volume] in Blood
1636
13287
1.09
2.62
2.8
3.1
e9/l
4.2
4.1
0.74
1178
9704
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
111
712
1.37
2.62
1.2
1.1
u/ml
3.1
14.9
—
7
63
(3005033) Fetal Nuchal fold Thickness US
66
856
0.68
2.61
1.3
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
16
59
2.38
2.55
1.6
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
516
3939
1.15
2.54
1.2
1.2
u/ml
7.9
5.6
0.23
41
303
(3052592) Norovirus Ag [Presence] in Stool
74
444
1.46
2.54
1.2
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
5749
48618
1.05
2.53
1.4
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
243
1745
1.22
2.44
1.7
1.5
u/ml
23.0
26.0
0.49
49
367
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
93
587
1.39
2.44
2.2
1.9
%
28.5
29.5
0.29
88
542
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
153
1042
1.29
2.42
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
326
2411
1.19
2.41
2.1
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
86
537
1.41
2.40
1.4
1.4
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
71
428
1.46
2.40
1.2
1.2
mmol/l
1.8
1.6
0.77
42
265
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2832
26232
0.94
2.39
5.1
4.8
%
33.6
32.9
2.32
1817
17311
(3025577) Chromium [Mass/volume] in Blood
206
1457
1.24
2.39
2.0
2.0
ug/l
2.4
2.4
0.03
169
1208
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
20
84
2.09
2.38
1.1
1.5
nmol/l
6.0
3.8
1.94
20
79
(3044242) Glucose [Moles/volume] in Arterial blood
156
1068
1.28
2.38
2.2
1.9
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
87
548
1.39
2.33
1.3
1.3
umol/l
3.1
3.2
0.16
77
504
(3036525) Urea [Moles/time] in 24 hour Urine
27
128
1.85
2.32
3.0
3.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
127
849
1.31
2.32
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
571
4422
1.14
2.32
3.5
3.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1104
8873
1.10
2.29
2.2
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1105
8882
1.10
2.28
2.2
2.3
g/l
7.4
7.5
0.10
748
6524
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
27
129
1.84
2.27
5.9
4.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
22
98
1.97
2.26
2.8
3.3
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
15
57
2.31
2.26
1.1
1.1
g/l
0.0
0.2
—
5
20
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1101
8854
1.10
2.26
2.2
2.3
g/l
3.8
3.8
0.01
721
6259
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
50
284
1.55
2.25
2.7
2.5
mg/l
91.1
80.7
—
5
40
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1685
13795
1.08
2.24
7.3
8.3
%
1.4
1.4
0.59
1674
13691
(44813793)
166
1157
1.26
2.22
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
176
1236
1.25
2.21
1.2
1.3
u/ml
1.0
1.4
0.46
86
639
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
249
1815
1.21
2.19
1.5
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1525
12452
1.08
2.19
2.5
2.4
au/ml
23.9
28.9
0.67
57
536
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1033
8300
1.10
2.17
2.2
2.3
g/l
10.3
10.2
0.12
812
6860
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
2889
24103
1.06
2.16
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
1040
8361
1.10
2.16
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
91
586
1.36
2.16
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
472
3630
1.14
2.15
1.4
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
146
0.36
2.15
1.2
1.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
9
26
3.04
2.14
1.4
2.7
mu/l
4.6
1.9
—
9
26
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
156
1085
1.26
2.14
1.1
1.1
nmol/l
8.2
7.4
0.05
29
220
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
153
1062
1.27
2.13
2.3
2.2
ug/min
60.8
119.6
1.03
42
237
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1677
13757
1.07
2.13
7.3
8.4
%
0.7
0.7
6.92
1663
13660
(3039443) Prostate specific Ag panel - Serum or Plasma
259
2701
0.84
2.08
1.7
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
708
5598
1.11
2.07
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1384
11287
1.08
2.07
1.3
1.3
au/ml
53.8
52.2
0.07
55
469
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2377
19749
1.06
2.06
2.0
2.2
g/l
0.2
0.2
0.28
2166
18250
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
421
3224
1.15
2.06
1.3
1.3
miu/ml
165.3
215.4
2.34
148
1287
(3010503) CD19 cells [#/volume] in Blood
163
1146
1.25
2.05
2.4
2.4
e9/l
0.7
0.4
0.33
158
1104
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
118
797
1.30
2.05
3.1
2.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
166
1171
1.25
2.03
2.0
2.1
umol/l
12.7
23.5
1.57
13
113
(3026470) Cobalt [Mass/volume] in Blood
208
1504
1.22
2.02
1.9
2.0
ug/l
4.1
3.9
0.08
185
1316
(3014007) Fractional oxyhemoglobin in Arterial blood
1676
13779
1.07
2.02
7.5
8.5
%
94.0
93.7
0.88
1664
13730
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
48
278
1.52
2.02
1.4
1.4
%
77.2
73.8
0.30
38
233
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
75
474
1.39
2.01
3.3
2.3
mmol/l
7.8
7.5
0.18
45
301
(3000764) Benzodiazepines [Presence] in Urine
281
2899
0.85
2.00
2.0
1.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
632
4982
1.12
1.97
1.2
1.2
titre
805.9
942.6
0.25
17
171
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
19
85
1.96
1.96
6.0
11.7
e6/l
119.1
314.0
0.86
13
66
(3051387) C reactive protein [Mass/volume] in Capillary blood
573
4493
1.12
1.96
3.8
3.6
mg/l
29.3
27.8
0.45
404
2859
(3027008) Opiates [Presence] in Urine
284
2921
0.85
1.96
2.0
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
285
2930
0.85
1.95
2.0
1.9
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
161
1138
1.24
1.95
1.2
1.1
u/l
82.3
89.1
0.64
114
903
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
88
575
1.34
1.94
1.3
1.4
%
17.8
21.4
0.71
68
484
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
161
1139
1.24
1.94
1.2
1.1
u/l
23.9
26.6
0.31
108
872
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
305
2293
1.17
1.93
2.0
2.0
u/l
4812.3
3964.6
0.22
97
853
(4146454)
331
2505
1.16
1.93
3.1
2.6
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
46
267
1.51
1.93
5.6
5.2
ug/min
52.2
47.7
0.14
35
221
(3035880) pH of Pleural fluid
184
1322
1.22
1.92
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
277
2848
0.85
1.91
2.0
1.9
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
14
56
2.19
1.91
1.1
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
193
1396
1.21
1.89
1.5
1.6
u/l
6.4
6.2
0.07
81
677
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
371
2837
1.15
1.89
1.5
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
485
3776
1.13
1.88
3.6
1.6
nmol/l
0.8
0.8
0.54
397
3119
(3038071) Oxygen [Partial pressure] in Mixed venous blood
67
421
1.40
1.88
16.4
7.9
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
112
763
1.29
1.86
7.0
6.4
mmol/l
25.1
25.0
0.10
105
681
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
5
10
4.39
1.86
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
864
6945
1.09
1.85
1.9
1.9
s
22.3
21.8
0.99
746
6160
(3045414) Leukocytes [Presence] in Urine
1114
9054
1.08
1.85
2.1
1.9
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
304
2296
1.16
1.84
1.3
1.2
u/ml
43.9
56.8
0.54
26
162
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
58
357
1.43
1.83
1.1
1.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
9
30
2.63
1.82
1.0
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
77
499
1.36
1.81
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
121
836
1.27
1.81
2.7
2.5
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
338
2578
1.15
1.80
4.9
4.5
umol/l
358.8
352.9
0.30
284
2176
(4034850)
808
6487
1.10
1.79
11.9
11.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
51
308
1.45
1.79
1.2
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
18
82
1.93
1.79
1.0
1.0
u/ml
0.1
0.0
—
8
55
(3014111) Lactate [Moles/volume] in Serum or Plasma
2292
19121
1.06
1.76
5.8
6.5
mmol/l
1.3
1.4
0.28
2198
18374
(3014765) Yersinia sp identified in Stool by Organism specific culture
708
5654
1.10
1.76
1.2
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
147
1043
1.24
1.76
1.5
1.5
%
4.9
3.2
0.33
32
223
(3046914) Granular casts [#/area] in Urine by Computer assisted method
11
41
2.36
1.75
1.5
1.3
u/field
0.5
0.6
—
6
21
(3023383) Lactate [Moles/volume] in Pleural fluid
108
739
1.28
1.75
1.3
1.3
mmol/l
3.3
3.4
0.08
98
676
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
436
3391
1.13
1.75
1.3
1.3
u/l
25.5
39.5
4.09
365
2927
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
945
7650
1.09
1.74
2.4
2.2
ug/l
664.6
549.0
0.22
885
7200
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
936
8894
0.92
1.71
1.8
1.8
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
708
5665
1.10
1.70
1.2
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
102
696
1.29
1.70
3.0
2.9
umol/l
29.5
28.2
0.46
72
527
(3021387) Prolactin [Units/volume] in Serum or Plasma
443
3458
1.13
1.69
1.9
1.7
mu/l
308.3
312.6
0.07
397
3162
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
81
536
1.33
1.68
1.3
1.3
%
33.1
37.6
0.43
50
351
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
18
84
1.88
1.68
1.0
1.0
u/ml
0.0
0.2
—
8
52
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
105
721
1.28
1.67
11.8
12.2
mmol/l
0.6
0.6
0.29
97
652
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
202
1489
1.19
1.67
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
626
4987
1.10
1.65
1.2
1.2
titre
86.0
145.5
2.38
48
418
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
228
1702
1.18
1.63
1.1
1.1
au/ml
108.7
64.3
—
5
30
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
575
4565
1.11
1.63
1.4
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
435
3401
1.12
1.62
1.6
1.5
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
85
570
1.31
1.62
1.8
1.8
mmol/l
0.2
0.6
0.31
79
537
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
198
2059
0.84
1.62
1.6
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
902
7321
1.08
1.59
3.2
3.0
g/l
0.5
0.3
2.29
403
2995
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
1085
10214
0.93
1.59
1.3
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
24
126
1.67
1.55
2.6
1.9
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
61
392
1.37
1.55
2.4
1.9
e6/l
123.3
1077.5
1.61
33
211
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
42
527
0.70
1.53
2.0
1.8
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
23
120
1.68
1.53
1.0
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
65
424
1.35
1.52
1.2
1.2
mg/l
0.7
39.0
1.26
50
317
(3020356) Listeria sp identified in Specimen by Organism specific culture
12
50
2.11
1.51
1.0
1.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
21
107
1.72
1.51
1.1
1.0
u/l
2.1
3.2
—
7
23
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
309
2378
1.14
1.51
1.2
1.2
u/l
57.3
61.1
0.58
215
1569
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
33
190
1.53
1.49
1.2
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1014
8295
1.08
1.49
2.3
2.3
g/l
3.0
3.1
1.70
730
6377
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
55
351
1.38
1.48
1.4
1.4
%
17.1
10.5
0.60
17
189
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
36
212
1.49
1.47
1.0
1.1
umol/24h
1.6
1.7
0.27
36
212
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
50
314
1.40
1.47
1.5
1.2
ng/l
87.9
384.3
0.62
31
215
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
25
135
1.63
1.47
1.1
1.1
u/field
1.2
1.1
0.24
19
85
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
353
2746
1.13
1.47
1.5
1.5
%
62.8
59.5
0.81
206
1726
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
142
1029
1.21
1.45
2.7
2.7
%
39.7
38.5
0.25
66
338
(4281824)
230
2337
0.86
1.45
1.2
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
51
323
1.39
1.44
1.3
1.2
mmol/l
3.0
1.1
0.81
31
209
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
90
621
1.27
1.42
2.1
1.9
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
194
1449
1.18
1.42
1.3
1.3
titre
59.1
61.3
0.05
22
114
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
193
1442
1.18
1.41
1.0
1.0
ng/l
731.9
712.9
0.20
121
951
(3027456) Digoxin [Moles/volume] in Serum or Plasma
632
5085
1.09
1.41
3.2
3.2
nmol/l
0.8
0.8
0.03
501
3934
(3033705) Calcium.ionized [Moles/volume] in Venous blood
377
2954
1.12
1.40
2.6
2.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
20
103
1.70
1.40
7.0
4.5
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
7
25
2.46
1.40
1.1
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
676
5458
1.09
1.39
2.1
2.1
%
92.4
90.2
1.79
626
5079
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
74
500
1.30
1.38
15.6
8.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
270
2702
0.88
1.38
2.0
1.9
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
187
1397
1.18
1.38
1.3
1.3
mmol/l
2.2
2.2
0.11
175
1291
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
193
1446
1.17
1.38
1.0
1.0
ng/l
42.9
44.1
0.15
121
976
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
144
0.49
1.36
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
298
2308
1.13
1.35
1.4
1.5
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
13
59
1.93
1.34
1.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
36
0.00
1.33
0.0
6.1
—
0.2
—
0
36
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
132
0.47
1.32
6.9
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
132
0.47
1.32
3.4
3.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1614
13464
1.06
1.31
1.7
1.7
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
8
29
2.42
1.31
1.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
42
510
0.72
1.30
2.5
2.3
nmol/l
108.2
153.3
2.59
34
438
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
25
140
1.57
1.30
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
191
1438
1.17
1.30
1.0
1.0
ng/l
379.8
326.5
0.62
125
986
(21494815) CD4 cells/100 lymphocytes in Specimen
194
1463
1.17
1.29
2.0
2.1
%
40.3
39.9
0.05
32
178
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
38
234
1.43
1.28
1.4
1.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
179
1343
1.17
1.28
1.3
1.2
mmol/l
11.0
12.0
0.90
57
404
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
289
2247
1.13
1.26
1.3
1.3
u/l
466.5
462.7
0.01
266
2130
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
34
206
1.45
1.25
1.1
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
965
7944
1.07
1.23
3.0
2.8
u/ml
0.3
0.4
0.46
547
4567
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
550
5254
0.92
1.23
1.7
1.7
mg/l
3.8
3.5
0.23
410
3767
(3004616) Nuclear Ab [Presence] in Serum
307
2400
1.12
1.23
1.3
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
630
5106
1.08
1.23
3.7
3.4
mmol/l
1.6
1.6
0.81
614
5000
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
37
229
1.42
1.22
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
80
557
1.26
1.22
2.5
2.9
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
37
230
1.41
1.20
1.1
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
37
230
1.41
1.20
1.1
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
175
1319
1.17
1.20
1.4
1.4
promille
1.2
1.2
0.02
141
994
(40758292) HTLV I+II Ab panel - Serum
19
264
0.63
1.20
1.3
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
43
275
1.37
1.19
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
282
2199
1.13
1.19
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
81
568
1.25
1.17
1.9
1.8
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
140
1039
1.18
1.16
1.4
1.4
nmol/l
1.2
1.2
0.03
98
801
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
18
251
0.63
1.16
1.7
1.5
—
—
—
0
0
(4038314)
0
32
0.00
1.15
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
356
2821
1.11
1.14
1.1
1.1
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
15
76
1.73
1.14
1.0
1.0
u/ml
0.3
0.8
—
8
50
(3035947) Staphylolysin Ab [Units/volume] in Serum
134
993
1.19
1.14
1.2
1.1
iu/ml
4.2
4.0
—
10
58
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
99
713
1.22
1.14
1.1
1.1
iu/ml
196.1
184.1
0.16
99
703
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
50
331
1.33
1.13
6.5
7.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
918
8563
0.94
1.11
4.1
4.0
mmol/l
24.7
24.9
1.28
819
7828
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1940
17739
0.96
1.11
1.7
1.7
%
1.6
1.5
0.91
1605
15090
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
364
2893
1.11
1.11
6.3
6.1
mg/l
12.6
12.1
1.21
332
2619
(3051671) S100 calcium binding protein B [Mass/volume] in Serum
12
57
1.85
1.11
2.6
2.4
ug/l
0.1
0.1
0.05
12
52
(3044927) Protein electrophoresis panel - Urine
309
2435
1.12
1.11
1.2
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
84
597
1.24
1.10
1.6
1.4
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
13
64
1.78
1.09
6.0
5.8
umol/l
528.0
415.7
0.62
13
64
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
17
91
1.64
1.08
1.4
1.6
u/l
0.3
0.3
—
6
25
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
619
5046
1.08
1.08
1.3
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
5802
52017
0.97
1.07
4.0
4.0
%
87.4
87.8
0.47
5645
50746
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
195
1497
1.14
1.07
1.3
1.3
titre
159.4
451.4
1.92
17
134
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
221
1711
1.13
1.07
1.9
1.8
mg/l
3.8
4.2
0.85
209
1612
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
28
347
0.71
1.03
3.2
3.1
ng/l
205.0
125.6
—
7
118
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
205
1585
1.14
1.03
1.7
1.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
595
4855
1.08
1.03
3.8
3.5
mmol/l
7.9
7.6
0.84
581
4762
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
665
5449
1.07
1.02
2.4
2.4
g/l
3.7
3.6
0.17
638
5166
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
77
548
1.23
1.02
4.1
5.9
%
71.8
69.5
0.33
67
430
(3038026) Centromere Ab [Units/volume] in Serum
209
1620
1.13
1.01
1.2
1.2
u/ml
102.0
53.8
—
8
78
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
52
353
1.29
1.01
1.9
1.7
mmol/l
1.2
1.2
0.08
52
340
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
906
7509
1.06
0.99
2.4
2.5
g/l
1.3
1.0
1.09
734
6341
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
34
217
1.38
0.99
2.1
1.9
umol/l
15.5
17.1
0.41
34
217
(3016018) Differential panel - Cerebral spinal fluid
242
1897
1.12
0.98
1.4
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
52
355
1.29
0.97
1.1
1.1
u/ml
0.6
0.9
0.29
22
174
(3003434) Protein [Mass/volume] in Pleural fluid
412
3321
1.09
0.97
1.4
1.5
g/l
30.5
32.4
2.35
370
2972
(3036782) Glucose [Moles/volume] in Pleural fluid
278
2199
1.11
0.97
1.3
1.3
mmol/l
6.6
6.3
0.50
262
2030
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1311
10992
1.05
0.95
1.4
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
166
1275
1.14
0.94
2.3
2.4
e6/l
685.5
719.9
0.13
78
528
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
202
1572
1.13
0.94
1.2
1.2
u/ml
79.3
87.8
0.21
15
67
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
144
1095
1.16
0.94
1.5
1.5
u/l
5.6
6.1
0.54
116
909
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
282
2238
1.11
0.93
1.1
1.1
%
119.6
118.6
0.19
243
2002
(3025315) Body weight
28
175
1.40
0.93
5.3
4.9
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
6
24
2.19
0.92
2.7
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
1320
11080
1.05
0.92
3.9
3.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
64
693
0.81
0.92
2.1
1.8
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
24
146
1.44
0.91
1.3
1.5
%
42.2
38.7
0.12
13
96
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
10
48
1.83
0.91
1.3
1.1
mmol/l
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
33
388
0.75
0.91
1.5
1.4
mmol/l
8.8
8.6
0.11
21
219
(46235355) HIV 1 and 2 tests - Meaningful Use set
2518
21422
1.03
0.91
1.8
1.6
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
192
1494
1.13
0.90
1.2
1.2
u/ml
2.3
7.3
1.54
12
98
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
234
2286
0.90
0.90
3.3
3.7
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
15
82
1.61
0.90
1.4
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
258
2043
1.11
0.90
1.5
1.5
%
25.7
28.8
0.79
145
1254
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
156
1198
1.14
0.90
1.7
2.0
u/field
3.6
2.4
0.60
115
818
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
202
1578
1.12
0.90
1.2
1.2
u/ml
18.0
47.1
2.89
17
122
(44806118)
272
2161
1.11
0.89
1.5
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
708
5850
1.06
0.89
1.4
1.4
—
—
—
0
0
(44790049)
272
2162
1.11
0.89
1.5
1.5
—
—
—
0
0
(44790048)
272
2162
1.11
0.89
1.5
1.5
—
—
—
0
0
(44790047)
272
2162
1.11
0.89
1.5
1.5
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
16
213
0.66
0.88
6.4
5.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
230
2243
0.90
0.87
2.0
1.9
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
17
97
1.54
0.87
1.4
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
122
923
1.16
0.87
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
70
504
1.22
0.86
1.6
1.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
24
148
1.42
0.86
1.0
1.1
u/l
6.6
11.5
1.25
24
148
(3006442) Creatine [Moles/volume] in Serum or Plasma
163
1260
1.14
0.86
1.6
1.6
umol/l
61.8
71.2
0.97
12
75
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3968
34029
1.03
0.86
3.2
3.0
e6/l
2.9
2.7
0.16
2281
18645
(21491868) Cryoglobulin [Mass/volume] in Serum
92
682
1.18
0.84
1.2
1.2
g/l
1.9
0.4
—
5
49
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
216
1702
1.11
0.84
1.3
1.4
u/l
13.8
13.0
0.72
205
1639
(3023183) Ammonium ion [Moles/volume] in Plasma
527
4322
1.07
0.84
2.4
2.4
umol/l
32.8
33.6
0.28
415
3592
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
41
278
1.29
0.84
1.1
1.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
63
451
1.23
0.83
1.5
1.5
ng/l
97.5
123.2
1.54
63
451
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
64
459
1.22
0.83
2.2
2.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
245
1946
1.11
0.83
1.1
1.1
u/ml
2.4
4.0
0.82
94
726
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
861
7956
0.95
0.83
1.7
1.7
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
43
295
1.28
0.81
1.3
1.3
u/l
40.1
296.9
0.97
28
212
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
22
0.00
0.79
0.0
1.1
—
—
—
0
0
(44806071)
30
196
1.34
0.79
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
544
4480
1.07
0.79
1.3
1.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
8
42
1.67
0.78
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
133
1023
1.14
0.78
1.2
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
499
4673
0.94
0.77
1.2
1.2
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
85
633
1.18
0.76
1.4
1.6
umol/l
2.1
2.0
0.56
78
585
(3008401) Mugwort IgE Ab [Units/volume] in Serum
199
1937
0.90
0.76
1.0
1.1
u/ml
0.8
1.0
0.36
76
774
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
39
267
1.28
0.76
1.2
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
97
731
1.17
0.76
2.1
1.9
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
18
108
1.46
0.76
1.4
1.3
u/field
1.0
1.1
0.15
11
65
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
23
145
1.39
0.76
1.1
1.4
ml/s/173m2
1.2
1.0
—
10
96
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
75
553
1.19
0.75
1.5
1.6
ug/l
0.3
0.4
0.62
37
360
(3004809) Band form neutrophils/100 leukocytes in Blood
441
3613
1.07
0.75
3.2
3.4
%
1.7
1.5
0.36
342
2785
(4035726)
2093
18930
0.97
0.75
1.4
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
41
453
0.79
0.75
1.1
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
46
323
1.25
0.74
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
176
1721
0.90
0.74
1.4
1.3
u/l
34.2
34.2
0.00
139
1403
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
100
1014
0.87
0.74
1.4
1.4
pmol/l
84.8
92.8
0.10
35
327
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
132
1312
0.88
0.73
1.0
1.1
mg/l
298.2
291.2
0.57
118
1162
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
147
1145
1.13
0.73
1.3
1.2
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
13
73
1.56
0.73
1.7
1.1
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
7
34
1.81
0.72
1.0
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
134
1039
1.13
0.72
3.1
3.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
102
776
1.15
0.72
2.1
3.1
mu/l
20.5
25.9
1.00
96
722
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
34
231
1.29
0.71
1.1
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
148
1457
0.89
0.71
1.7
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
148
1157
1.12
0.70
1.3
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
127
0.62
0.70
1.2
1.1
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
9
51
1.55
0.69
1.0
1.1
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
11
149
0.65
0.69
1.1
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
11
60
1.61
0.69
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
32
360
0.78
0.69
1.5
1.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
19
118
1.41
0.69
1.1
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
59
431
1.20
0.68
1.2
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
563
4672
1.06
0.67
2.9
3.2
u/ml
653.6
924.7
0.41
516
4233
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
77
789
0.86
0.67
1.2
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
174
1379
1.11
0.66
1.3
1.2
u/l
95.5
88.1
0.39
147
1201
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
299
2430
1.08
0.66
1.2
1.2
u/ml
3.7
4.3
0.25
98
824
(3032743) Legionella sp IgG Ab [Presence] in Serum
11
147
0.66
0.66
1.1
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
466
4342
0.94
0.65
1.2
1.2
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
113
0.62
0.64
1.4
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
11
146
0.66
0.64
1.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
98
752
1.14
0.64
1.3
1.4
—
—
—
0
0
(4198724)
37
404
0.80
0.64
1.7
2.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
100
769
1.14
0.63
2.2
2.3
umol/l
59.7
55.5
0.59
79
593
(3032352) Blasts [#/volume] in Cerebral spinal fluid
28
189
1.30
0.63
1.5
1.7
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
22
143
1.35
0.63
2.7
2.5
pmol/l
13.8
51.5
—
5
49
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
68
508
1.18
0.62
1.7
1.6
ug/l
9.8
9.2
0.44
68
508
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
93
933
0.87
0.62
1.6
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
169
1343
1.11
0.62
1.2
1.2
u/l
22.2
24.9
0.46
141
1139
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
260
2108
1.08
0.62
2.7
2.8
—
—
—
0
0
(4306422)
286
2328
1.08
0.62
1.2
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
290
2363
1.08
0.61
1.1
1.1
au/ml
9.7
13.9
0.49
13
89
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1191
10091
1.04
0.61
5.0
4.0
mmol/l
24.0
24.2
1.06
1055
9046
(3013676) Sertraline [Moles/volume] in Serum or Plasma
0
17
0.00
0.61
0.0
1.4
—
176.7
—
0
10
(3002079) Sodium [Moles/time] in 24 hour Urine
0
17
0.00
0.61
0.0
1.1
—
130.1
—
0
17
(3009992) Blasts/100 cells in Bone marrow
0
18
0.00
0.61
0.0
1.7
—
15.9
—
0
18
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
123
0.64
0.60
1.6
2.5
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
222
1791
1.09
0.60
1.3
1.3
u/l
15.5
13.1
0.50
202
1655
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
160
1271
1.11
0.60
2.1
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
214
2044
0.92
0.60
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
140
1365
0.90
0.60
2.6
2.4
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
106
823
1.13
0.59
1.4
1.4
umol/l
23.6
25.2
0.22
101
773
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
214
2042
0.92
0.59
1.6
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
232
2206
0.92
0.59
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
47
495
0.83
0.58
1.2
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
44
318
1.21
0.58
1.3
1.3
%
22.0
23.8
0.12
26
257
(40762814) Titanium [Mass/volume] in Blood
42
447
0.82
0.58
2.3
2.2
ug/l
2.7
3.8
1.85
15
157
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
101
783
1.13
0.58
1.6
1.8
umol/l
120.1
113.3
0.06
55
424
(3044640) Blood type and Crossmatch panel - Blood
7339
65179
0.98
0.58
2.5
2.5
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
122
1195
0.90
0.58
1.0
1.0
u/ml
0.1
0.5
1.47
22
288
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
8
47
1.49
0.57
10.4
8.9
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
21
138
1.34
0.57
1.6
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
130
1025
1.11
0.57
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
67
505
1.16
0.57
1.1
1.3
nmol/l
105.0
135.1
1.45
54
354
(3005570) Glucose [Moles/volume] in Urine
268
2186
1.08
0.57
2.2
1.9
—
1.5
—
0
8
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
26
177
1.29
0.56
1.0
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
179
1436
1.09
0.56
1.5
2.0
mmol/l
7.8
7.1
1.45
115
998
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
77
0.57
0.56
1.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
67
506
1.16
0.56
1.1
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
2118
18143
1.03
0.56
7.4
7.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
64
482
1.17
0.55
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
64
482
1.17
0.55
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
64
482
1.17
0.55
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
64
482
1.17
0.55
1.1
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
11
64
1.51
0.55
1.0
1.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
317
2606
1.07
0.55
1.1
1.1
iu/ml
2641.7
4742.4
0.17
71
515
(1002224) Polysomnography panel
642
5894
0.95
0.55
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
41
434
0.83
0.55
2.1
2.5
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
66
499
1.16
0.55
1.3
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
9
52
1.52
0.54
1.0
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
17
109
1.37
0.54
1.1
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
349
2881
1.06
0.54
2.1
2.1
mg/l
27.7
26.7
0.10
69
772
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
12
150
0.70
0.54
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
535
4927
0.95
0.53
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
535
4926
0.95
0.53
1.3
1.3
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
52
387
1.18
0.53
4.3
2.5
ml/dl
14.5
14.8
0.43
45
361
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
186
1502
1.09
0.52
1.5
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
217
2055
0.93
0.52
1.2
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
11
65
1.49
0.52
67.7
10.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
184
1486
1.09
0.52
2.5
2.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
1097
9945
0.97
0.51
3.8
3.8
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
97
758
1.12
0.51
1.1
1.1
ng/l
1618.7
573.3
0.32
24
186
(3036312) Salmon IgE Ab [Units/volume] in Serum
13
80
1.43
0.51
1.0
1.0
u/ml
0.0
0.2
—
8
58
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
9
120
0.66
0.51
1.0
1.4
—
20827.0
—
0
7
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
9
56
1.41
0.51
1.7
1.3
nmol/l
354.6
508.1
—
9
56
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
502
4196
1.05
0.51
1.6
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
125
992
1.11
0.51
1.1
1.1
—
—
—
0
0
(3036603) Volume of Urine
173
1395
1.09
0.51
1.8
1.6
ml
1656.7
1945.0
1.47
47
364
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
11
138
0.70
0.51
1.0
1.0
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
17
198
0.75
0.51
3.6
2.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
368
3051
1.06
0.51
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
189
1531
1.08
0.50
1.5
1.4
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
14
88
1.40
0.50
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
63
479
1.15
0.50
1.0
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
135
1077
1.10
0.50
1.4
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
135
1077
1.10
0.50
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
56
422
1.17
0.50
1.3
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
1600
13686
1.03
0.49
3.9
3.1
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
70
700
0.88
0.49
2.2
1.8
e6/l
4815.3
11236.1
1.19
40
374
(3017354) Segmented neutrophils/100 leukocytes in Blood
244
2292
0.93
0.49
3.1
3.4
%
61.5
58.6
1.10
142
1478
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
89
876
0.89
0.48
4.2
4.7
u/ml
867.5
5331.4
0.44
11
131
(3025886) Oxalate [Mass/time] in 24 hour Urine
7
40
1.54
0.48
1.3
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
68
522
1.14
0.48
1.7
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
71
708
0.88
0.48
1.5
1.7
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
273
2248
1.07
0.48
1.4
1.5
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
13
156
0.73
0.47
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
21
143
1.29
0.47
1.2
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
30
214
1.23
0.47
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
283
2336
1.06
0.46
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
171
1386
1.08
0.46
3.4
3.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
33
349
0.83
0.46
1.4
1.2
%
103.9
71.3
—
8
107
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
121
1166
0.91
0.46
1.7
1.7
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
136
1092
1.09
0.46
1.3
1.7
umol/l
10.5
10.3
0.03
84
793
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
121
1165
0.91
0.45
1.7
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
121
1165
0.91
0.45
1.7
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
121
1165
0.91
0.45
1.7
1.7
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
12
75
1.40
0.45
1.0
1.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
158
1279
1.08
0.45
1.7
1.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
47
354
1.17
0.44
1.5
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
81
635
1.12
0.43
1.3
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
266
2478
0.94
0.43
3.5
3.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
72
711
0.89
0.43
2.0
1.7
ug/l
6.1
4.6
0.26
53
508
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
69
683
0.89
0.43
13.7
11.0
nmol/l
809.9
844.4
0.29
63
645
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
5
27
1.63
0.43
1.8
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
31
225
1.21
0.43
9.7
9.9
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
8
49
1.43
0.42
1.0
1.0
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
91
885
0.90
0.42
1.1
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
83
653
1.12
0.42
1.1
1.1
—
—
—
0
0
(3026906) Gabapentin [Moles/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
1.1
—
67.8
—
0
8
(3040794) Aluminum [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
8
52
1.35
0.40
1.5
1.3
%
1.5
1.3
—
8
52
(3017461) Flecainide [Moles/volume] in Serum or Plasma
19
131
1.27
0.40
1.4
1.6
umol/l
0.8
0.8
0.07
13
92
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
16
0.00
0.40
0.0
1.2
—
29.6
—
0
16
(3000093) Morphology [Interpretation] in Blood Narrative
256
2121
1.06
0.40
1.2
1.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
801
6811
1.03
0.40
1.6
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
391
3277
1.05
0.40
1.4
1.3
u/l
12.3
12.1
0.10
321
2628
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
49
374
1.15
0.40
1.2
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
685
5809
1.04
0.40
1.4
1.4
iu/ml
15.6
15.1
—
10
142
(3044009) aPTT.lupus sensitive (LA screen)
12
141
0.75
0.40
1.0
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
329
2746
1.05
0.39
1.8
1.9
pmol/l
192.1
193.4
0.08
301
2557
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
82
648
1.11
0.39
1.3
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
323
2695
1.05
0.39
1.4
1.5
e6/l
68555.5
55536.6
0.23
182
1611
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
164
1339
1.08
0.39
1.2
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
110
883
1.09
0.39
1.2
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
68
668
0.89
0.39
1.5
1.4
—
—
—
0
0
(4094501)
629
5329
1.04
0.39
1.1
1.1
—
—
—
0
0
(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method
13
85
1.34
0.39
1.2
1.1
u/field
0.8
1.3
—
8
50
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
164
1340
1.07
0.39
1.2
1.1
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
31
1.42
0.39
1.8
4.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
281
2601
0.95
0.39
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
324
2706
1.05
0.38
1.3
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
30
313
0.84
0.38
2.8
2.7
u/field
0.2
0.6
3.45
30
313
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
164
1341
1.07
0.38
1.2
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
14
93
1.32
0.38
1.1
1.4
umol/24h
399.5
327.2
0.34
14
93
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2769
23925
1.02
0.38
3.8
3.9
ug/l
17.2
25.8
1.05
2291
19628
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
227
0.81
0.38
1.1
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
123
995
1.09
0.38
1.0
1.1
iu/ml
7.7
10.1
0.56
21
216
(3010726) Horse dander IgE Ab [Units/volume] in Serum
207
1709
1.06
0.37
1.0
1.1
u/ml
2.3
1.7
0.16
44
387
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
149
1216
1.08
0.37
1.7
1.5
g/l
0.9
0.9
0.66
149
1202
(1761482) Bacteria [#/volume] in Urine by Culture
718
6106
1.03
0.37
4.7
4.5
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
23
245
0.82
0.37
1.3
1.1
u/l
14.6
19.3
1.27
17
164
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
13
86
1.33
0.37
7.0
8.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
137
1295
0.93
0.36
1.9
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
194
1811
0.94
0.36
1.1
1.1
—
—
—
0
0
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
0.9
1.0
—
5
62
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
0.6
3.0
—
9
72
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
0.7
1.2
—
7
63
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
2.5
2.2
—
7
66
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
1.2
2.0
—
5
57
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
5.6
3.7
—
8
62
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
4.6
3.3
—
9
66
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
14
94
1.31
0.36
1.3
1.6
mg/l
2.2
2.5
—
9
67
(3052851) Hemolysis interference index of Serum or Plasma
737
6669
0.97
0.36
3.6
3.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
177
1456
1.07
0.36
1.0
1.1
u/ml
2.8
3.4
0.20
63
557
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
34
348
0.86
0.36
1.6
1.1
%
100.9
81.4
0.89
12
109
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
48
370
1.14
0.35
1.4
1.7
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
9
108
0.73
0.35
1.1
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
23
166
1.22
0.35
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
36
366
0.86
0.35
4.7
5.2
u/l
43.9
60.4
0.61
17
145
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
90
864
0.91
0.35
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
162
1332
1.07
0.34
1.2
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
236
2184
0.95
0.34
1.5
1.6
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
37
281
1.16
0.34
1.1
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
132
1078
1.08
0.34
2.4
2.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
181
1495
1.06
0.33
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
1414
12160
1.02
0.33
2.1
2.1
nmol/l
11.8
12.0
0.48
1230
10506
(3003888) Timothy IgE Ab [Units/volume] in Serum
216
2001
0.95
0.33
1.0
1.1
u/ml
3.3
3.9
0.24
100
946
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
162
1335
1.07
0.32
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
162
1335
1.07
0.32
1.2
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
211
1955
0.95
0.32
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
13
88
1.30
0.32
1.1
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
149
1395
0.94
0.32
1.3
1.3
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
47
365
1.13
0.32
1.5
1.6
ug/l
96.3
114.8
0.83
40
302
(3000492) Spirometry study
1852
16531
0.98
0.32
1.5
1.5
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
135
0.78
0.31
1.5
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
109
1030
0.93
0.31
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
29
296
0.86
0.31
1.2
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
766
6548
1.03
0.30
2.2
2.3
g/l
0.0
0.0
0.05
679
5937
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
14
97
1.27
0.30
1.3
1.6
mg/l
0.3
2.1
—
8
64
(3020123) Porphyrins [Interpretation] in Serum or Plasma
14
97
1.27
0.30
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
196
1814
0.95
0.30
1.1
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
27
202
1.17
0.30
1.1
1.1
u/ml
75.5
58.8
0.46
27
193
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
404
3419
1.04
0.30
1.7
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
141
1317
0.94
0.29
4.1
3.8
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
24
178
1.18
0.29
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
43
335
1.13
0.29
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
327
2759
1.04
0.29
1.3
1.3
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
7
50
1.23
0.29
1.0
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
48
377
1.12
0.29
1.1
1.1
pmol/l
28.0
3.4
—
9
41
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
52
506
0.90
0.28
1.2
1.1
%
85.9
86.5
0.03
26
242
(3025130) Human papilloma virus identified in Specimen
215
1799
1.05
0.28
1.6
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
923
7925
1.02
0.27
1.3
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
13
142
0.80
0.27
1.0
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
281
2367
1.04
0.27
1.2
1.2
u/ml
3.8
4.0
0.10
118
1053
(4212803)
22
227
0.85
0.27
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
497
4495
0.97
0.27
1.4
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
173
1600
0.95
0.27
1.1
1.0
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
51
495
0.90
0.27
1.4
1.4
g/l
28.1
41.8
0.57
44
381
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
33
254
1.14
0.27
1.5
1.4
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
18
131
1.21
0.27
1.2
1.5
%
17.7
13.3
0.42
11
90
(4024509)
240
2200
0.96
0.27
1.6
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
206
1895
0.95
0.26
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
206
1895
0.95
0.26
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
206
1895
0.95
0.26
1.5
1.6
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
31
238
1.14
0.26
1.1
1.2
ug/l
105.8
107.1
0.02
19
149
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
53
512
0.91
0.26
1.1
1.1
%
88.2
86.5
0.14
25
240
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
16
169
0.83
0.25
1.2
1.3
nmol/l
0.2
0.2
—
8
111
(3011288) Drugs identified in Urine by Screen method
207
1900
0.96
0.25
2.7
2.6
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
37
289
1.12
0.25
1.5
1.5
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
23
234
0.86
0.25
1.1
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
30
231
1.14
0.25
1.6
1.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
10
68
1.29
0.24
2.7
1.6
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
12
84
1.25
0.24
1.0
1.0
u/ml
0.0
0.7
—
7
66
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1040
9298
0.98
0.24
1.9
2.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
34
265
1.13
0.24
3.4
2.4
pmol/l
78.3
76.5
0.04
29
233
(3050794) Legionella sp Ab [Presence] in Serum
17
177
0.84
0.24
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
27
207
1.14
0.24
1.0
1.1
—
—
—
0
0
(4211845)
121
1124
0.94
0.23
4.2
3.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
53
425
1.09
0.23
1.1
1.3
mu/l
81.7
72.8
0.09
37
302
(3027696) Helicobacter pylori Ab [Titer] in Serum
5
33
1.33
0.23
1.2
1.1
titre
3220.0
1799.7
—
5
33
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
53
508
0.92
0.23
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
251
2287
0.96
0.23
1.1
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
288
2441
1.04
0.23
2.9
3.3
nmol/l
6.0
9.5
0.78
280
2368
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
15
157
0.84
0.22
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
349
2969
1.03
0.22
1.4
1.5
e6/l
3519.4
2646.0
0.20
261
2143
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
85
797
0.94
0.22
1.1
1.1
u/ml
4.8
6.1
0.25
11
121
(3018851) Theophylline [Moles/volume] in Serum or Plasma
29
225
1.13
0.22
1.9
1.6
umol/l
43.4
46.9
0.19
29
225
(3024522) Salmonella sp identified in Specimen by Organism specific culture
306
2775
0.97
0.22
1.4
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
34
267
1.12
0.22
2.2
2.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
594
5333
0.98
0.21
1.5
1.6
e6/l
11310.1
14610.3
1.90
448
3828
(3034426) Prothrombin time (PT)
65
529
1.08
0.21
1.1
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
67
546
1.08
0.21
1.5
1.4
g/l
14.7
13.7
0.42
48
420
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
112
930
1.06
0.21
1.4
1.3
g/l
1.6
1.5
—
9
82
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
133
1227
0.95
0.21
1.4
1.4
umol/l
12.1
13.6
2.07
126
1155
(3023487) Leukocytes [#/volume] in Peritoneal fluid
84
786
0.94
0.21
2.2
1.9
e6/l
6079.2
2511.4
0.29
63
529
(4015189)
80
657
1.07
0.21
2.3
2.3
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
19
143
1.17
0.21
2.8
1.7
%
12.8
18.3
0.48
12
71
(3036180) Methadone [Presence] in Urine
0
11
0.00
0.21
0.0
2.4
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
13
94
1.21
0.21
1.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
46
441
0.92
0.21
1.3
1.3
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
64
522
1.08
0.20
1.2
1.2
%
116.9
112.5
0.61
59
455
(3013166) Neutrophils/100 leukocytes in Synovial fluid
71
667
0.93
0.20
1.3
1.4
%
67.4
57.1
1.83
59
569
(3022475) Manganese [Moles/volume] in Blood
10
108
0.81
0.20
1.1
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
9
98
0.81
0.20
1.7
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
494
4235
1.02
0.20
1.1
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
111
1.19
0.20
1.1
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
112
1035
0.95
0.20
4.4
3.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
244
2071
1.03
0.19
1.2
1.2
mmol/l
7.9
7.6
0.48
195
1457
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
45
1.17
0.19
1.0
1.1
%
2.2
2.4
—
6
45
(3015183) Erythrocyte sedimentation rate
69
647
0.94
0.19
1.2
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
24
186
1.13
0.19
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
204
1726
1.04
0.19
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
480
4311
0.98
0.19
1.8
1.8
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
12
87
1.21
0.19
1.0
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
901
8038
0.98
0.19
3.0
3.3
u/ml
3775.7
1312.4
0.40
760
6848
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
12
126
0.84
0.19
1.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
19
191
0.87
0.19
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
802
6919
1.02
0.18
2.1
2.2
g/l
37.5
37.3
0.54
659
5841
(3011335) Digoxin [Mass/volume] in Serum or Plasma
28
220
1.12
0.18
1.6
2.4
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
28
220
1.12
0.18
1.1
1.2
mg/l
7.9
8.5
0.13
22
209
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
68
559
1.07
0.18
1.2
1.2
g/l
0.3
0.3
0.80
57
449
(3021788) Differential panel - Synovial fluid
447
4015
0.98
0.18
1.5
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
45
428
0.92
0.18
6.4
5.8
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
7
51
1.20
0.18
1.6
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
23
227
0.89
0.18
1.2
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
481
4131
1.02
0.18
1.4
1.4
pmol/l
222.4
170.8
0.90
463
4024
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
587
5054
1.02
0.17
2.5
2.3
%
199.1
200.4
0.12
549
4757
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
441
3785
1.02
0.17
1.6
1.7
nmol/l
46.2
44.0
0.79
434
3628
(43055514) Macroprolactin [Presence] in Serum or Plasma
30
238
1.11
0.17
1.6
1.4
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
21
208
0.89
0.17
1.1
1.1
iu/ml
6.4
19.7
—
5
73
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
99
913
0.95
0.17
1.7
1.9
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
7
55
1.12
0.17
1.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
36
289
1.09
0.17
1.1
1.4
%
46.6
50.9
0.17
13
134
(40765096) Chromosome analysis panel by Banding
66
616
0.94
0.17
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
59
0.74
0.17
1.0
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
15
113
1.17
0.17
1.1
1.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
161
1362
1.04
0.16
1.0
1.1
u/ml
2.9
3.0
0.01
60
521
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
101
846
1.05
0.16
1.9
1.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
43
350
1.08
0.15
4.6
2.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
243
2074
1.03
0.15
1.3
1.4
e6/l
201336.8
123260.7
0.61
153
1425
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
9
68
1.16
0.15
1.1
1.0
—
—
—
0
0
(4133840)
52
427
1.07
0.15
1.3
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
21
206
0.89
0.15
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
49
460
0.93
0.15
1.1
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
98
900
0.96
0.15
1.7
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
98
900
0.96
0.15
1.7
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
279
2387
1.03
0.15
1.3
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
9
70
1.13
0.15
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
307
2759
0.98
0.15
1.4
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
574
4954
1.02
0.14
1.5
1.5
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
13
98
1.16
0.14
1.1
1.2
ng/l
11089.1
2666.5
—
7
63
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
32
258
1.09
0.14
2.3
2.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
325
2916
0.98
0.14
1.7
1.8
ug/l
19.8
24.2
1.44
315
2845
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
262
2243
1.03
0.14
3.1
3.8
u/ml
39.6
55.3
1.06
257
2207
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
42
395
0.93
0.14
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
380
3402
0.98
0.14
1.4
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
8
84
0.84
0.14
2.0
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
546
4719
1.02
0.13
2.6
2.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
12
121
0.87
0.12
1.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
28
226
1.09
0.12
1.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
60
554
0.95
0.12
1.0
1.0
u/ml
0.2
1.1
—
10
89
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
164
1481
0.97
0.12
1.1
1.2
—
—
—
0
0
(44806420)
84
707
1.04
0.12
2.1
2.4
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
23
184
1.10
0.12
2.6
1.8
%
69.7
60.8
1.05
18
112
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
962
8534
0.99
0.12
1.8
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
316
2828
0.98
0.12
1.4
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
142
1.11
0.12
1.0
1.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
78
714
0.96
0.11
1.3
1.3
ug/l
420.6
264.4
0.24
40
398
(3001729) Color of Synovial fluid
19
184
0.91
0.11
1.7
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
224
1922
1.02
0.11
1.1
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
115
1043
0.97
0.11
1.5
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
37
346
0.94
0.11
1.7
1.6
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
19
151
1.10
0.11
1.1
1.0
u/ml
0.0
5.8
—
9
118
(3020874) Milk IgE Ab [Units/volume] in Serum
75
686
0.96
0.11
1.0
1.0
u/ml
0.3
1.4
1.33
23
218
(3047189) Immunofixation for 24 hour Urine
125
1064
1.03
0.11
1.8
1.7
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
75
632
1.04
0.10
1.5
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
24
194
1.09
0.10
1.1
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
5
38
1.15
0.10
2.4
2.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
4354
38069
1.00
0.10
3.2
3.2
ug/l
0.8
0.8
0.19
3097
26712
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
18
173
0.91
0.09
1.1
1.1
u/ml
0.0
0.6
1.49
12
114
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
33
308
0.94
0.09
1.1
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
190
1704
0.98
0.09
1.1
1.1
%
97.2
94.6
0.67
172
1583
(3010370) Gastrin [Moles/volume] in Serum or Plasma
36
298
1.06
0.09
1.8
1.8
pmol/l
35.0
63.1
1.60
29
240
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
284
2451
1.02
0.09
1.1
1.1
g/l
1.5
1.5
0.21
254
2202
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
10
100
0.88
0.09
1.0
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
103
931
0.97
0.09
1.8
1.9
%
97.5
97.4
0.01
96
869
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
12
118
0.89
0.09
1.1
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
40
333
1.05
0.09
1.0
1.0
u/ml
7.5
10.5
—
6
49
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
11
85
1.14
0.09
1.1
1.1
mmol/l
8.2
8.4
0.15
11
85
(3014599) Egg white IgE Ab [Units/volume] in Serum
73
664
0.96
0.09
1.0
1.0
u/ml
0.3
1.2
1.36
18
175
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
59
497
1.04
0.09
1.1
1.1
—
—
—
0
0
(4268621)
184
1582
1.02
0.09
2.3
2.3
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
27
253
0.94
0.09
1.2
1.3
mmol/l
7.2
6.2
0.28
12
116
(3008536) Aspergillus sp Ab [Presence] in Serum
44
405
0.95
0.08
1.9
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2660
23241
1.01
0.08
2.8
2.6
umol/l
9.5
9.1
0.29
2252
20172
(3002256) Pathology report gross observation
3045
26836
1.00
0.08
1.3
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
119
1018
1.03
0.08
1.1
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
53
0.83
0.08
1.4
1.5
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
5
54
0.81
0.08
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
5
54
0.81
0.08
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
5
54
0.81
0.08
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
5
54
0.81
0.08
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
5
57
0.77
0.08
1.0
1.0
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
12
94
1.12
0.08
1.0
1.0
u/ml
0.1
0.2
—
7
63
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
43
360
1.05
0.08
1.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
125
1071
1.02
0.08
1.0
1.2
u/l
222.4
318.4
0.72
108
997
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
183
1576
1.02
0.08
4.5
5.0
u/ml
115.4
131.6
0.09
38
461
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
126
1132
0.98
0.08
1.6
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
126
1132
0.98
0.08
1.6
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
307
2732
0.99
0.08
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
307
2732
0.99
0.08
1.4
1.4
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
60
1.02
0.07
1.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
64
0.82
0.07
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
504
4469
0.99
0.07
1.3
1.4
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
8
65
1.08
0.07
1.1
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
137
1178
1.02
0.07
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
170
1519
0.98
0.07
1.4
1.4
nmol/l
0.2
0.3
2.63
122
1093
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
8
81
0.87
0.06
1.0
1.1
nmol/l
225.1
276.1
—
8
81
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
10
98
0.90
0.06
9.6
8.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
308
2736
0.99
0.06
1.4
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
534
4725
0.99
0.06
1.3
1.3
iu/l
33.4
35.0
0.53
465
4063
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
53
450
1.03
0.06
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
35
294
1.04
0.06
1.4
1.2
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
19
178
0.94
0.06
1.8
2.0
mmol/l
0.7
1.2
—
8
114
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
27
225
1.05
0.06
3.6
3.1
mg/l
1.4
1.2
0.20
21
169
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
135
1164
1.02
0.06
5.9
6.4
—
—
—
0
0
(3019225) pH of Specimen
2529
22268
1.00
0.06
4.5
4.3
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
45
381
1.04
0.05
1.4
1.7
ug/l
2.2
2.5
0.20
25
222
(3026726) Creatinine [Moles/volume] in Specimen
22
182
1.06
0.05
2.5
2.5
umol/l
442.0
352.4
0.18
22
173
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
114
1020
0.98
0.05
1.5
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
330
2925
0.99
0.05
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1150
10045
1.01
0.05
3.4
3.8
u/ml
90.5
62.5
0.46
1099
9677
(3011325) HIV 1+2 Ab [Presence] in Serum
10
79
1.11
0.05
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
217
1928
0.99
0.05
1.5
1.5
iu/ml
18.6
29.0
—
5
97
(3044007) Cell count panel - Peritoneal fluid
69
621
0.98
0.05
2.1
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
355
3089
1.01
0.05
1.3
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
16
131
1.07
0.05
1.1
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
11
88
1.10
0.05
1.0
1.0
u/ml
0.0
1.0
—
6
67
(3024263) Appearance of Synovial fluid
131
1132
1.02
0.04
1.6
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
32
292
0.96
0.04
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
93
801
1.02
0.04
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
93
801
1.02
0.04
1.2
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
15
140
0.94
0.03
1.3
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
258
2246
1.01
0.03
1.1
1.1
u/ml
1.4
1.2
0.09
96
862
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
48
432
0.98
0.03
1.6
1.7
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
14
115
1.07
0.03
1.1
1.4
%
1.5
1.3
—
6
74
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
104
900
1.01
0.03
1.2
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
164
1454
0.99
0.03
1.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
48
412
1.02
0.02
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
586
5163
1.00
0.02
1.3
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
34
290
1.03
0.02
1.5
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
294
2568
1.00
0.02
1.4
1.5
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
17
143
1.04
0.01
2.5
2.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
58
502
1.01
0.01
1.0
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
699
6124
1.00
0.01
2.2
2.4
g/l
0.0
0.0
0.08
618
5534
(3036670) Protein [Mass/volume] in Synovial fluid
82
713
1.01
0.01
1.2
1.3
g/l
40.6
39.5
0.30
45
371
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
25
214
1.03
0.00
1.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
175
1542
1.00
0.00
1.2
1.2
titre
93.2
176.5
3.12
25
287
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
124
1094
0.99
0.00
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
46
409
0.99
0.00
1.1
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
18
163
0.97
0.00
1.2
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
12
108
0.98
0.00
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
53
469
0.99
0.00
1.1
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
19
168
0.99
0.00
1.7
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
18
157
1.01
0.00
2.2
2.4
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
10
92
0.95
0.00
1.1
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
14
118
1.04
0.00
1.7
1.6
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
57
499
1.00
0.00
1.1
1.2
pmol/l
426.6
291.9
0.78
39
348
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
175
1539
1.00
0.00
1.2
1.2
titre
104.0
154.2
—
10
55
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
67
584
1.01
0.00
2.0
2.0
u/l
21.5
42.5
1.86
60
532
(3051611) Lipemic interference index of Serum or Plasma
271
2377
1.00
0.00
3.6
3.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
42
368
1.00
0.00
1.1
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
687
6028
1.00
0.00
2.2
2.4
g/l
0.0
0.0
0.00
616
5514
(40757373) Influenza virus identified in Isolate
50
438
1.00
0.00
1.5
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
37
329
0.99
0.00
1.6
2.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
124
1091
1.00
0.00
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
57
498
1.00
0.00
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
57
498
1.00
0.00
1.1
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
23
203
0.99
0.00
2.5
2.6
mmol/l
8.9
7.2
1.57
12
111
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
5
51
0.86
0.00
1.8
1.4
%
0.5
0.5
—
5
44
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
9
78
1.01
0.00
1.0
1.0
—
—
—
0
0
(3039542) Porphyrins [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033463) Neutrophils [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
65.4
—
0
5
(3013762) Body weight Measured
5
51
0.86
0.00
1.0
1.2
—
—
—
0
0
(3014178) Parietal cell Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3019529) Immunofixation for Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
60
0.88
0.00
1.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint H7_GLAUCOMA and mortality.

Females

Parameter HR [95% CI] p-value
H7_GLAUCOMA 0.927 [0.86, 1.0] 0.046
Birth year 0.992 [0.98, 1.0] 0.05

During the follow-up period (1.1.1998 — 31.12.2019), 24916 out of 98423 females with H7_GLAUCOMA died.

Males

Parameter HR [95% CI] p-value
H7_GLAUCOMA 0.94 [0.86, 1.02] 0.154
Birth year 0.994 [0.99, 1.0] 0.13

During the follow-up period (1.1.1998 — 31.12.2019), 16495 out of 60846 males with H7_GLAUCOMA died.

Mortality risk

Mortality risk for people of age

years, who have H7_GLAUCOMA.

N-year risk Females Males
1 0.067% 0.183%
5 0.499% 1.275%
10 1.171% 3.165%
15 2.168% 5.955%
20 3.707% 10.966%

Relationships between endpoints

Index endpoint: H7_GLAUCOMA – Glaucoma

GWS hits: 110

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data